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INTRODUCTION
Precision nutrition is an emerging field with limited application at the time of this eBook
construction. Scientific advancements and research in precision nutrition currently exceed the
application that is evident in many clinical settings. Precision nutrition depends on scores of data
from patients, including but not limited to genetic, microbiome, anthropometric, cultural
influences, personal preferences, etc. Despite the data requirements, the utility and
effectiveness that could underlie precision nutrition in practice is astounding. There is not one
diet that “works” for everyone, but there is a dietary pattern that works for each person. (The
word “works” is used to infer optimization of health and wellness while reducing disease risk.)
The reality of this statement becomes apparent when reviewing the research, that Clinical
Nutrition research, that illustrates disparate outcomes despite participants strictly adhering to
the same dietary protocols.
Culinary medicine is not dietetics, internal medicine, nor is it a culinary school. Instead, culinary
medicine is an evidence-based field that aims to educate and inform patients and practitioners
about culinary strategies to put nutrition recommendations into practice. Culinary medicine
courses emerged in medical education in 2003 in upstate New York. Since that time, culinary
medicine courses have been integrated into medical schools across the nation, mostly as elective
courses. Culinary medicine offers ways to understand and appreciate the patient’s understanding
of food and cooking as part of his or her care and apply that understanding to a patient’s health
care goals.
Bridging precision nutrition and culinary medicine takes the latest nutritional sciences research
around individualized nutrition and combines it with practical strategies for implementation in
the kitchen.
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Culinary Exercise Preparation
Preparing for culinary exercises means becoming familiar with elements of food preparation and
cooking, such as measurement (quantitative and qualitative), food safety, and knife skills. This
chapter will introduce and explore these concepts to facilitate a knowledgeable, effective, and
safe culinary experience.
Measurements in the Kitchen
Measurement is essential to critical fields of study and inquiry, such as mathematics, physics, and
chemistry. While the stakes are not as high in culinary practice as compared to quantum physics
or structural engineering, measurement remains essential in cooking and culinary practice. Every
measurement provides three kinds of information: the size or magnitude of the measurement (a
number); a standard of comparison for the measurement (a unit); and an indication of the
uncertainty of the measurement. The number and unit are explicitly represented when a quantity
is written. As an example, a bag of rice is 5 kg (11 lb.). Five (5) is the number and kg, or kilogram,
is the unit of measurement. The metric system provides the most widely used units of
measurements in the world; the International System of Units (SI) is based on the metric system.
The U.S. Customary System is also widely used in the United States for culinary processes and
food preparation (Table 2.1). Accurately converting between these two systems of measurement
(see Table 2.2) is important for the sake of any recipes where units need converting. Recipes
referenced in NS801 will utilize the U.S. Customary System of Units.
Table 2.1:

The Most Common Units of Measurements in Culinary Processes

MEASUREMENT International System of Units,
SI
LENGTH
meter (m)
VOLUME
liter (L); meter cube (m3)
WEIGHT
gram (g)
TEMPERATURE Celsius,
Table 2.2:

U.S. Customary System of Units
inch (in)
fluid ounce (fl oz); gallon (gal); quart (qt)
pound (lb); ounce (oz)
Fahrenheit

Common Conversion Factors for the Length, Volume, and Weight Measurements
MEASUREMENT
Length
Volume
Weight

CONVERSION FACTOR
1 in. = 2.54 cm
1 m = 100 cm
1 L = 1,000 mL
1 L = 33.8 fl. Oz (U.S.)
1 L = 0.264 gal (U.S.
1 kg = 1,000 g
1 lb = 454 g
1 lb = 16 oz (U.S.)
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The Case for Food Safety at Home
Foodborne illness is 100% preventable, and yet, 56,000 people per year become ill from
foodborne causes in the United States, creating high economic costs, loss of productivity and
reduced quality of life for many. Experts agree that the home is the primary location where
foodborne outbreaks occur; however, many consumers do not believe the home to be a risky
place. Health care professionals need to be aware of consumers’ food safety attitudes and
behaviors in the home and deliver tailored food safety interventions. Small steps and minor
actions can prevent foodborne illnesses.
In recent years, headlines, and news flashes on widespread outbreaks of foodborne disease
caused by lapses in food safety or emerging pathogens have provided vivid reminders that food
not only nourishes and sustains us, but if handled unsafely, can be a major threat to health and
well-being. According to FoodNet, the United States’ food safety report card, considerable
progress had been made toward decreasing foodborne illnesses caused by key pathogens, except
for Salmonella. The decline is good news, but this rate is still higher than Healthy People 2020
goals, and many people continue to suffer the ill effects of foodborne illness. Experts estimate
that each year 1 in 6 Americans experience foodborne illness—resulting in of the known
hospitalizations of 56,000 and death of more than 1,300.
Home is the location most often associated with significant foodborne illness risk. This is because
a vast majority of food eaten is prepared at home, thereby increasing the opportunities for food
handling errors to occur. The emphasis frequently placed on how often people “eat out” causes
many to not realize that the home food environment provides 72% of the food, by weight,
consumed by Americans and accounts for 93% of the food consumed by those who eat most
meals at home.
Health professionals should be aware that there are select groups of people who are at increased
risk of foodborne illness, such as generally young and older populations, pregnant women, etc.
And these groups make up a sizable portion of the population. For example, 13% of Americans
are 65 years and over, 7% are less than 5 years old, and almost 4 million women (about twice the
population of New Mexico) are pregnant every year, and 1% is immunocompromised due to
disease, medical treatment, and/or organ transplant. In addition to this, 12 million people are
receiving healthcare at home as an extension of or replacement for traditional in-patient care.
This amounts to one quarter of the U.S. population being at increased risk for foodborne disease
and at elevated risk for severe health outcomes if they become ill.
Many consumers—even those in high-risk groups—do not perceive themselves or someone in
their families to be susceptible to foodborne illness, rank their risk of foodborne illness lower
than that of others, or do not follow all recommended food safety practices. Consequently, they
do not take enough precautions. For instance, young infants are particularly vulnerable to
infections due to their immature immune systems which makes scrupulous cleaning and handling
of equipment associated with infant feeding critical. Although women report they become
6

interested in food safety after they have a baby, there are numerous documented food handling
mistakes regarding infant feeding. Researchers in the United Kingdom, for example, found that
4% of baby bottles that parents indicated had been cleaned, disinfected, and ready to be filled
were contaminated with Staphylococcus aureus.
Additionally, food prepared in the home may be served to a wider community, such as at bake
sales, church dinners, and school picnics. Even foods children trade at lunchtime or homemade
snacks adults share with colleagues in the workplace can be a source of foodborne illness. Food
samples served at farm market stands also are commonly prepared in home kitchens. At least
one-fifth of young children in the United States also are in home-based (non-parental) child-care
where food may be served. Unlike commercial enterprises, home kitchens are multipurpose
areas and are much more than just food preparation and storage places. For instance,
researchers have observed women’s purses that once sat on public ladies’ restroom floors were
sitting on kitchen counters. Pets, old newspapers, dirty laundry, house plants, and soil all are
common in-home kitchens—one research team even reported observing a home kitchen where
automotive repairs were occurring. Kitchen sinks are used for hand washing, produce washing,
dishwashing, soaking clothing, washing children and pets, and wetting mops. Dirty dishes may be
stacked alongside clean dishes on kitchen counters. Raw unwashed vegetables, dripping raw
meat, as well as cooked ready-to-eat foods are common in home refrigerators. The multiple uses
of home kitchens potentially introduce an array of pathogens that can spread to foods,
proliferate, and result in illness. Some of the pathogens that have been confirmed in home
kitchens include Salmonella, pathogenic Escherichia coli, S. aureus, and Campylobacter. At least
two studies have reported that the kitchen is more heavily contaminated with fecal coliforms
than bathrooms.
On the positive side, about 6 in 10 consumers recognize they are responsible for food safety, and
nearly all agree that they gave at least some thought to food safety in the past year. But there
are gaps in consumer applications of Clean, Separate, Chill, and Cook advice from the Dietary
Guidelines for Americans and food safety programs like Fight Bac! Inconsistent practices among
home food handlers can negate much of the effort made in improving and maintaining food
safety achieved earlier in the food chain.
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Principles of Food Safety at Home
The main principles of food safety discussed herein include Clean, Separate, Chill, and Cook.
I. Clean
The goal of “clean” is to prevent cross contamination—or the transfer of disease-causing
microorganisms from one food, object, or surface to another food—by washing hands, food
contact surfaces, and kitchen equipment. Hands are a major vehicle for spreading pathogens
around the kitchen—thus hand washing is critical to preventing cross contamination. Survey data
indicates that almost all consumers report washing their hands with soap for a full 20 s before
preparing food all or most of the time. Most consumers also report they often or always wash
their hands after handling raw meat. Despite consumers’ awareness of the importance of hand
washing, they are not washing their hands thoroughly. For example, after handling raw chicken,
73 to 100% of hands of consumers who reported washing their hands after touching the meat in
a research study were contaminated with Campylobacter jejuni. None of the consumers
sufficiently washed their hands to prevent C. jejuni transfer to salads after handling the raw
chicken. Little is known about how often during meal preparation consumers wash their hands.
Given how often the most heavily contaminated areas in the kitchen (i.e., refrigerator handles,
tea kettle handles, tap handles, sink drain areas, dishcloths, and sponges) are touched during
meal preparation, it is possible, if not likely, that hands are not washed frequently enough to
prevent the transfer of pathogens to ready-to-eat food, food packaging, or equipment and
contact surfaces used to prepare food.
Dishcloths, kitchen rags, and cleaning sponges quickly become heavily contaminated with a
diverse array of microbes, harboring, and spreading contamination to hands, kitchen equipment,
and contact surfaces. High numbers of E. coli survive in dishcloths for at least 48 h. Consumers
have room for improvement when using sponges and sanitizing dishcloths—of the 92% of
consumers who use them, just 9% report changing dishcloths or sponges daily, 44% change them
at least weekly, the remainder change them less often, with 5% waiting until they fall apart.
Kitchen utensils and cutting boards also are key cross contamination routes. In fact, research in
the United Kingdom suggests that 14% of all foodborne illnesses may be due to inadequately
cleaned cutting boards and knives. Although nearly all consumers report they wash these items
after using them with raw meat or produce, observational data indicate that most consumers do
not clean cutting boards and utensils sufficiently to prevent cross contamination. Cleaning of
food products prior to consumption and preparation is another vital component of “clean”. A
recent study recommended that consumers use a 3% hydrogen peroxide solution (which is
readily available at pharmacies) to wash cantaloupes prior to cutting. A misperception remains
that washing raw poultry removes “germs,” hence providing clear and accurate information
regarding which food products require washing (and how to properly do so) before preparation
is needed.
A new cross-contamination vehicle that has the potential to pose a significant risk of bacterial
cross contamination is the reusable grocery bag. One in three consumers report using these bags
8

for more than just groceries —they double as gym bags, toy bags, and other uses. This is a
concern given that 75% of consumers use these same bags for carrying raw meat and other foods.
Large numbers of bacteria (including fecal coliforms) were found in every reusable bag collected
from consumers outside a grocery store, but none were found in new bags or traditional plastic
bags. Despite the effectiveness of removing pathogens by washing reusable grocery bags, only
3% of consumers reported regularly washing them. Dirty reusable grocery bags could pose a
foodborne illness risk—an outbreak of norovirus in a girls’ soccer team was traced to a
contaminated reusable grocery bag
II. Separate
“Separate,” like “clean,” is vital to preventing cross contamination. The goal of “separate” is to
keep raw meat, poultry, and seafood separate from ready-to-eat foods like salads and cooked
meat. About three-quarters of consumers report keeping raw meat, poultry, and seafood
separate from ready-to-eat food products, and nine in ten use different plates for raw and cooked
meat. However, there is room for improvement, especially considering that meat, poultry, and
seafood are the leading causes of foodborne illness.
III. Chill
“Chill” focuses on the refrigerator’s critical role in temperature control. But it is important to also
think about “clean” and “separate” in this appliance. Studies indicate that refrigerators in many
households are not clean. One study from Ireland reported that more than half of the
refrigerators swabbed had at least one of these pathogens: S. aureus, Salmonella enterica, E. coli,
Listeria monocytogenes and Yersinia enterocolitica. Many refrigerators are also not cool enough,
with average temperatures exceeding the recommended 40 °F (5 °C).This problem has been
noted in the U.S., U.K., Ireland, New Zealand, and Australia. Compounding the cooling problem
is that refrigerators often are packed so tightly with food that air circulation is restricted. Tight
packing also increases food-to-food cross-contamination risk. Only one-quarter of consumers
report regularly checking refrigerator temperatures, and another quarter do not even have a
refrigerator thermometer. One positive note is that 60% of those in the U.S. know the safe
temperature for refrigerators to be less than 40 °F (5 °C). Another aspect of “chill” is keeping
perishable foods out of danger zone temperatures. Most consumers (79%) reported leaving
prepared perishable food at room temperature no longer than the recommended 2-hour
timeframe and two-thirds report thawing food in the refrigerator. There also is a common
misconception that cooked foods should be cooled to room temperature before being placed in
the refrigerator.
IV. Cook
Among the four principles discussed here, the greatest area needing improvement is “cook”—
according to Healthy People 2020, only about 37% of consumers achieve the goal of heating
foods, such as meat and poultry, to a temperature sufficiently high enough to kill harmful
pathogens. Almost 9 in 10 consumers know that ground beef should be cooked to at least 160 °F
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(71 °C) and two-thirds report they usually cook meats and poultry to this temperature. However,
most do not know that color is not a good indicator of doneness and less than a quarter validate
the accuracy of the cooking temperature with a thermometer. Consumers continue not to use
thermometers despite knowing that the greatest food poisoning risk is from undercooked foods
and that “germs” in food are serious dangers. Many consumers report that thermometers are
inconvenient and difficult to use, especially with small cuts of meat, which contributes to low
rates of thermometer use. Many express frustrations with needing to remember the different
temperature recommendations for beef, poultry, and seafood. Also, recipes and cooking show
seldom give endpoint temperatures —recommending color as an indicator of meat doneness
three times more often than temperature. Color recommendations and lack of thermometer use
in televised cooking shows may lead consumers to view using food thermometers as a sign of
being an inexperienced cook. But visual inspection is risky—for instance, 70% of the chicken
pieces consumers judged as “done” by visual inspection had not reached recommended cooking
temperature and had active C. jejuni cells. Microwave ovens are ubiquitous in-home kitchens
throughout the developed world and play a key role in achieving the “cook” goal. Many
consumers report that they regularly follow cooking, flipping, rotating, stirring, and standing
instructions and check to be sure food is fully heated before eating. However, few use a
thermometer to verify food has been sufficiently heated in a microwave. In addition, microwave
ovens are seldom cleaned and present a cross-contamination risk.
V.
A Note on Risky foods
A fifth category of food safety practices that typically is not part of most food safety campaigns
is eating “risky” foods. Substantial proportions of the population consume foods that pose a
significant foodborne illness risk, such as undercooked animal flesh. For instance, more than half
of U.S. consumers report eating raw cookie dough (made with raw eggs), two-fifths consume raw
eggs, a quarter eat raw fish, one-fifth eat undercooked hamburgers, and an eighth eat raw
oysters.
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Four Practical Strategies for Health Professionals to Promote Food Safety
I. Boost knowledge
For behaviors associated with the primary principles of food safety (Clean, Separate, Chill, and
Cook), many consumers are aware of the food safety basics (wash your hands, cook pork
thoroughly, etc.). Consumers also understand that germs - even in food - can be harmful.
However, many consumers have food safety knowledge gaps, and their knowledge of safe food
handling practices does not always correspond with reported use and practical application. This
suggests a need to build consumer knowledge, activate existing knowledge, and motivate
information application and practice.
II. Highlight responsibility
Consumers are less likely to take protective steps if they believe their risk of foodborne illness is
controlled by fate or luck, and when minimizing their responsibility to that of others in the food
safety chain. Some feel they have little responsibility because they believe most foodborne
illnesses are caused earlier in the food safety chain or by retail food establishments. Helping
consumers understand the magnitude of control they have in their own homes as food safety
risk managers and finding motivators—such as helping them understand that by using a
thermometer, loved ones are less likely become sick from undercooked meat or showing them
how easy thermometers are to use—can help promote behavior change.
III. Bring awareness to susceptibility and severity
Engaging in health protective behaviors is associated with greater perceived susceptibility or
beliefs in the likelihood of a negative health outcome and its severity. For example, those who
believe food poisoning is a personal threat eat risky foods less often or not at all. Personalizing
risks can help consumers better understand their own foodborne illness susceptibility. Thus,
interventions should help consumers learn who is at increased risk for foodborne illness as better
knowledge of these groups predicts better compliance with safe food handling
recommendations.
IV. Suggest cues to action
Researchers have reported that consumers take food safety precautions only when they perceive
a risk, such as when they handle raw poultry, fear they may give others food poisoning, or when
others are watching. At other times, consumers may be acting out of habit and make food
handling mistakes because they lack “cues to action”. Fein and colleagues use the analogy of
driving a car—drivers are constantly taking protective actions in response to cues, such as the
yellow stripe in the middle of the road or a stop sign. But, when preparing and cooking food,
hazards are not visible (e.g., pathogens on the unwashed produce that contaminate the counter
and our hands) and there are few, if any, cues to remind us to practice safe food handling. Risk
messages or handling instructions on food packages can help to cue some to change their
behavior. In one study investigating cues to protective food safety behaviors, the control group
received a chicken salad recipe, and the experimental group received the same recipe with a
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printed message encouraging them to take great care to avoid cross contaminating the salad by
preventing raw meat juices from encountering other ingredients and utensils. Interestingly,
salads made by the group receiving the cue had significantly less bacteria than those made by
the control group, putting the experimental group at a four-fold lower relative risk of falling ill
than the control group. Another study that involved preparing a chicken salad recipe found that
only 57% of important hygiene measures (e.g., washing hands with soap and water, checking
doneness with a thermometer) were used by participants. Adding food safety cues to food
packages may be particularly effective, given that half of consumers indicate they commonly read
cooking instructions on food packages [57]. Practical cues that could be shared with patients for
implementation in the home kitchen include:
• Placing soap dispensers in direct line of sight to help improve hand washing [164].
• Printing washing instructions on reusable grocery bags could cue consumers to wash
them.
• Distributing a quick reference guide for endpoint cooking temperatures of various
proteins. Keeping the endpoint temperatures within sight of the cooking area could
increase temperature checking.
• Adding endpoint cooking temperatures in recipes and cookbooks.
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Knife Skills
This chapter includes information on how to choose knives, take care of them, and cut almost
anything (but please, do not cut yourself!). Information herein may not confer the heightened
knife skills that you might take away from culinary school, but they are the skills that home chefs
and cooks consider the easiest, quickest, and safest paths to preparing the food we want to cook.
How to Hold a Knife
The gripping hand (or cutting hand), which grips the knife, has the star turn, but the other hand
is an important supporting player. The helping hand holds, nudges, and stabilizes the ingredient
being cut, to maximize safety and efficiency.
Gripping Hand: For the knife grip used by most chefs, the palm of the hand chokes up on the
handle, while the thumb and index finger grip the top of the blade. This is different from how
many home cooks hold a knife, by wrapping the entire hand around the handle. The chef’s grip
has evolved that way for a reason: it is the most efficient way to use the weight of the knife, the
sharpness of its blade, and the strength of your arms, which makes for the easiest cutting.
Helping Hand: The ideal position for the helping hand is called the bear claw, with the fingertips
curled under and knuckles pressing down on the ingredient to keep it from rolling or sliding. It
may feel odd, but it is the safest place for your fingertips to be in relation to the cutting blade.
Alternatively, bunch your fingertips together and rest the pads on top of the ingredient.
In a perfect world, while the hand that is holding the knife moves forward and back to cut, the
helping hand moves across in even increments, creating perfect slices. (Do not despair; this takes
practice and is hardly a requirement for home cooks.)
Tips for the Grip:
Overall, the best way to handle a knife is the way it feels safe to you. Here are a few principles to
live by:
1. The knife handle should not be held in a death grip: try to relax hands and wrists and let
the blade do the cutting.
2. Position all 10 fingers so it is impossible for the blade to cut them.
3. The hand holding the knife should be gripping the blade as well as the handle.
4. The knife moves in a rocking motion, from front to back, as well as up and down.
5. The knife should be at the same height or just below your elbows, so that the whole
upper body, not just the hands, can put downward pressure on the knife.
The Cuts:
• Chop
If a basic task like chopping carrots takes forever, it can make cooking seem like a punishment.
That’s why becoming efficient with a knife is so helpful. And in that effort, chopping is your
greatest ally. Unlike professional chefs, who routinely dice their ingredients into measured cubes,
home cooks can usually keep it rough, if all the pieces end up about the same size.
• Dice
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More exact than chopping, dicing is the process by which vegetables and fruits, in all their
irregular and lumpy glory, are turned into small, neat cubes that cook uniformly. Whether chefs
are prepping a giant potato or a baby carrot, they reduce the curves and bumps to cubic shapes.
When that cube is cut along horizontal and vertical lines, neat dice is the result. The videos linked
in our online course demonstrate larger to smaller diced ingredients.
• Slice and Cut
When cutting ingredients into larger pieces – like a round slice of tomato, lemon or cucumber, or
a wedge of apple – the choice of knife and how it moves most often depend on the texture of
the ingredient. Although a super-sharp chef’s knife can be used to slice a tomato or lemon in
quick downward strokes, many home cooks will prefer the controlled back-and-forth sawing
motion of a serrated knife. Either way, the goal is to have smooth slices of even thickness.
• Chiffonade and Julienne
Home cooks are most likely to use these long, slim cuts for ingredients that are going into stirfries and salads, for tough greens destined for the cooking pot, or to make fluffy garnishes from
soft herbs and scallions. They are also useful for making raw vegetable platters look their most
elegant.
Your Basic Knife Drawer:
In any craft, having just the right tool for the job makes the task easier. In cooking, there are
knives for specific tasks like carving, filleting, and slicing. But with just a few versatile knives, you
can perform virtually any task in the kitchen. These are the knives you will use most often in your
kitchen. With these three, you can perform almost any task.
• Chef’s knife: A classic chef’s knife, with its broad, tapering blade, sharp tip and chunky handle
is the workhorse of the kitchen. Practicing with one really will make you a better cook: they
are sharper, stronger and they do more of the work for you than smaller knives. For many
home cooks, an 8-inch blade with a plastic handle is perfect, especially to start. Work up to a
10-inch knife, which is more efficient overall. When buying, look for a comfortable handle
and a blade that is thicker at the base than at the tip.
• Utility knife: These small knives are in constant use in most home kitchens, so it’s worth
having three or four. Many home cooks use these knives for every job: their short blades, 3
to 4 inches long, make them easier to control. They are best for small soft ingredients like
shallots, mushrooms, and peaches. Inexpensive thin-bladed knives with plastic handles are
often the most practical choice. Small knives are difficult for home cooks to sharpen, and so
simply replacing them when they get dull is nothing to be ashamed of.
• Serrated knife: A large, serrated knife (a 10-inch blade is standard) is useful not only for slicing
bread but for sawing through ingredients with firm rinds like butternut squash, lemons,
watermelon, and pineapples. The scalloped forefront makes neat slices of soft-skinned
ingredients like tomatoes and eggplants.
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Sharpening and Storage
How often do you sharpen your knives? Home cooks have a lot of things to take care of, and
knives do not often make it to the top of the list. But keeping knives sharp saves time eventually,
and it keeps you safe as well: sharp knives cut, but dull knives slip. This eBook will tell you how
to sharpen and hone your knives (both necessary) and how to store them. Associated videos are
available on the NS801 course shell.
Sharpening
Once a knife is dull – test it by drawing the blade along the edge of a piece of paper to see if it
cuts – it needs to be sharpened. We strongly recommend using manual, not electric sharpeners.
It is too easy to get carried away, exerting too much pressure, and making too many strokes,
while the whirling machine eats the edge of your knife. With a manual sharpener, use gentle
pressure while pulling the knife through, and test often as you go.
Honing
Many people do not know the difference between honing and sharpening. But they are equally
important for efficient knife work. Honing, which makes the blade of a knife straight, is done with
what is often (and incorrectly) called a sharpening steel, by drawing the blade over and over along
an abrasive rod of metal, ceramic, or stone. Many professionals hone their chefs’ knives daily but
doing it weekly is plenty for most home cooks. It is a quick process once you feel confident – and
it’s fun, making you look, feel, and sound like a serious cook. But remember honing helps
maintain the blade’s sharpness but does not actually sharpen it.
Tips for Knife Care and Storage
1. Do not wait until a knife gets dull before taking care of it. The easiest system involves
keeping your knives sharp in the first place, by giving them a quick honing and sharpening
every few weeks.
2. Use a cutting surface that will not dull them. Glass cutting boards are much too hard.
Wood is gentlest, and thick plastic is next best. Make sure boards stay firmly in place on
the counter by laying a kitchen towel underneath.
3. For storage, prevent nicks — including microscopic ones that dull the blade — by keeping
knives away from one another. Store them in a block or on a magnetic strip; place them
in a drawer if you do not want to use counter or wall space.
4. There is no reason a knife with a synthetic handle and a stainless-steel or ceramic blade
cannot be safely washed in the dishwasher — but you must place them so the knife
cannot get jostled around or the edge cannot be chipped. But knives with wood handles,
high-carbon-steel blades and other sensitive materials should be washed by hand.
5. Small utility knives with very thin, flexible blades cannot be sharpened, so it is best to
find an inexpensive type that you like and replace them often. Serrated knives cannot be
sharpened either, so keep them out of harm’s way.
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3. Emerging Concepts in Precision Nutrition
Adequate nutrition is essential to life. Beyond this, nutrition is a key factor for the prevention,
mitigation and treatment of various diseases and health conditions. Hippocrates, known as the
father of modern medicine, once said: “Let the food be thy medicine and the medicine be thy
food.” Since the days of Hippocrates, the understanding of nutrition and nutritional sciences,
and the mechanisms by which nutrients can modulate cellular signaling responses and affect
health risks, have been dramatically broadened. Food and nutritional scientists continue to
explore and investigate mechanisms by which nutritional components can either prevent or
induce characteristics of various disease states, in hopes of identifying key levers in the fight
against conditions such as diabetes, cancer, and Alzheimer’s disease. Some of the most
consistent and common nutritional guidelines include the messages in Table 3.1.
1.
2.
3.
4.

Table 3.1 Evidence-based & well-established dietary recommendations
Establish healthy limits for salt (sodium), added sugar, and saturated fat.
Use portion control, or calorie limits
Drink plenty of water
Consume plenty of fresh or frozen fruits and vegetables.

The Dietary Guidelines for Americans (DGA) are a set of dietary recommendations based on the
latest scientific research that is updated every five years. Yet, clinical nutrition research has
shown repeatedly that dietary protocols for one cohort of consumers yield different outcomes
in another. The totality of distinctions and differences from person to person in terms of genetics,
microbiome, and lifestyle make the case for personalized nutritional recommendations that
consider all such information. Precision nutrition in research and practice considers multiple
levels of influence that define an individual’s specific dietary needs, such as genetic background,
microbiome, metabolism, physical activity, environmental exposures, and other factors.
Precision nutrition focuses on the individual rather than groups of people, in stark contrast to the
DGA. Thus, precision nutrition considers not only “healthy” foods, but the “right” foods for an
individual. Is it possible that what is beneficial to one person may not be beneficial for another?
The field of precision nutrition says “yes” to that question.
This chapter will explore emerging concepts in precision nutrition, which will be further explained
within additional chapters of this text. Understanding the inter-relationships between these will
be important for developing targeted and specific dietary interventions to improve the health of
an increasingly diverse U.S. population. The underpinning goal of precision nutrition is to reveal
the precise amounts of macro and micronutrients needed to achieve the maximum health benefit
on an individual level. Another theory supporting precision nutrition is that optimizing the intakes
of specific nutrients could maximize their individual and collective effects.
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Defining Precision Nutrition
In general, precision nutrition is thought to include three important tenets:
1. The provision of nutritional advice adapted to an individual’s unique internal and external
influences. It is a specially tailored recommendation of a dietary habit for an individual to
maintain good health and lifestyle and prevent disease.
2. Precision nutritional interventions can only be effective if they translate into behavioral
change towards a healthy lifestyle.
3. Precision nutrition should be applicable to healthy individuals as well as patients afflicted
with, or susceptible to, specific medical conditions.
Because of its origins during the period of genomic sequencing, the term still partially overlaps
with some closely related terms such as nutrigenomics, nutrigenetics, gene-food interactions,
etc., but precision nutrition is multifaceted and includes an individual’s behavior, dietary
habits/cultural influence, food availability, phenotypic and genetic makeup, metabolism and
even the microbiome. (Maulik) Indeed, precision nutrition evaluates one’s DNA, microbiome, and
metabolic response to specific foods or dietary patterns to determine the most effective eating
plan to prevent or treat disease. The specific dietary recommendations based on genetic,
metabolomic, or microbiome-based information in this text will be identified throughout this
eBook with a PN notation.
Multiple terms and definitions are used during discussions of precision medicine and nutrition,
sometimes without clarity on details. In addition to the term precision nutrition, many other
terms are used— for example, personalized nutrition, stratified nutrition, tailored nutrition, and
individually tailored nutrition (Table 3.2; adapted from Table 2.1 in Maulik).
Table 3.2 Terms to Describe Precision Medicine & Precision Nutrition
Precision nutrition is the most ambitious of the descriptors. It suggests that it is possible to
have enough quantitative understanding about the complex relationships between an
individual, his/her food consumption, and his/her phenotype (including health) to offer
nutritional intervention/advice, which is known to be individually beneficial. The degree of
scientific certainty required for precision nutrition is greater than that required for other
approaches.
Stratified and tailored nutrition are similar. These approaches attempt to group individuals
with shared characteristics and to deliver nutritional intervention/advice that is suited to
each group.
Personalized nutrition and individually tailored nutrition mean similar things and more
specifically attempt to deliver nutritional intervention/advice suited to everyone.
Nutrigenetics is an aspect of personalized nutrition that studies the different phenotypic
responses (e.g., weight, blood pressure, plasma cholesterol or glucose levels) to a specific
diet (e.g., low fat or Mediterranean diets), depending on the genotype of the individual.
Nutrigenomics involves the characterization of all gene products affected by nutrients and
their metabolic consequences.
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Exposome is the collection of environmental factors, such as stress, physical activity, and
diet, to which an individual is exposed, and which may affect health. As one moves from
stratified to personalized to precision nutrition, it becomes necessary to apply more and
more dimensions or characteristics to achieve the desired goal. For example, stratification
could be undertaken using one, or a few, dimensions such as age, gender, or health status. In
contrast, given the complexity of relationships between individual diet and phenotype,
deployment of a wide range of dimensions/characteristics, perhaps including “big data”
approaches, would be necessary to achieve the goal of precision nutrition. An exception to
this broad generalization is the management of inborn errors of metabolism such as
phenylketonuria, where “precision nutrition” can be achieved using information on a single
characteristic— that is, genotype.
Epigenomics is a branch of genomics concerned with the epigenetic changes (methylation,
histone modification, microRNAs) that modify the expression and function of the genetic
material of an organism.
Metabolomics is the scientific study and analysis of the metabolites (usually restricted to
small molecules, e.g., < 900 Daltons) produced by a cell, tissue, or organism.
Microbiomics is the study of microbiome, the totality of microbes in specific environments
(e.g., the human gut).
According to the International Society of Nutrigenetics/Nutrigenomics, there are three overall
levels of precision nutrition, with stratified being the most generalizable, followed by
individualized and then genotype-directed (Figure 3.1).
Figure 3.1. Three levels of Precision Nutrition
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Nutrient-Gene Interactions
The diet-gene interaction is the most researched aspect of the field, with several examples of
researched gene-food interactions published to date. (Table 3.3) Though individuals share most
of their genes in common, the few differences are enough to cause significant alterations in
phenotype, including the way individuals respond to their diet. Changes to phenotype may evoke
changes in behavior, physiological characteristics, or susceptibility to diseases as well. Of these
genetic differences held accountable for phenotypic diversity, it is increasingly apparent that
single nucleotide polymorphisms (SNPs), the most known and common genetic variations
between human beings, will be a key factor. The study of diet-gene interactions can be loosely
sub-classified into two distinct study areas: nutrigenetics and nutrigenomics.
Nutrigenetics deals with how genetic makeup influences the way nutrients are acquired,
metabolized, and stored, while nutrigenomics is the study of how food components influence
gene expression. Nutrigenetics plays more of a preventative role, delineating the foods that
should be avoided because they could place the individual at risk for disease. On the other hand,
nutrigenomics also has the potential to transform diet into a therapeutic tool to treat diseases,
like pharmaceutical drugs. It is based on identification of genetic risk factors and targeting of key
players of gene expression at any given stage, to up or downregulate the effects of certain genes.
Table 3.3. Genetic Variants Effect Health Outcomes Associated with Specific Dietary Factors.
GENETIC VARIANTS THAT MODIFY THE LINK BETWEEN DIETARY FACTORS &
HEALTH OUTCOMES
Gene
Function
Dietary Factor
Health Outcomes
CYP1A2
Encodes CYP1A2 liver
Caffeine (Coffee, tea, Cardiovascular health
enzyme; metabolizes
soda, energy drinks,
endurance
caffeine; identifies
caffeine
individuals as fast or slow
supplements)
metabolizers
ADORA2A
Regulates myocardial
Caffeine (Coffee, tea, Vigilance when
oxygen demand; increases
soda, energy drinks,
fatigued, sleep
coronary circulation via
caffeine
quality
vasodilation
supplements)
BCMO1
Converts pro-vitamin A
Bluefin tuna, hard
Visuo-motor skills
carotenoids to Vitamin A
goat cheese, eggs,
and immunity
mackerel, carrots,
sweet potato
HFE
Regulates intestinal iron
Iron (beef, chicken,
Hereditary
uptake
fish, organ meats,
hemochromatosis
almonds, spinach)
TMPRSS6
Regulate the peptide
Iron (beef, chicken,
Iron-deficiency risk
hormone hepcidin, which
fish, organ meats,
controls iron absorption
almonds, spinach)
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FUT2

GSTT1

GC and
CYP2R1

Involved in vitamin B12 cell
transport and absorption

Vitamin B12 (Clams,
oysters, herring,
nutritional yeast,
beef, salmon)
Role in vitamin C utilization
Vitamin C (red
via glutathione S-transferase peppers,
enzymes
strawberries,
pineapple, oranges,
broccoli)
GC encodes vitamin DVitamin D (salmon,
binding protein, involved in white fish, rainbow
binding and transporting vit trout, halibut, milk)
D to tissues; CYP2R1
encodes the enzyme vitamin
D 25-hydroxylase involved in
vit D activation

Megaloblastic
anemia and
hyperhomocysteine
mia
Circulating ascorbic
acid levels mitigate
exercise-induced ROS
production
Circulating 25 (OH) D
levels effect
immunity, bone
health, inflammation,
strength training and
recovery
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The Microbiome
IOM (Institute of Medicine). 2013. The human microbiome, diet, and health: Workshop summary.
Washington, DC: The National Academies Press.
Table 3.4 KEY TERMS THAT HELP DEFINE AND DESCRIBE THE MICROBIOME
Commensal:
An organism participating in a symbiotic relationship in which
one species derives some benefit while the other is unaffected
Enterotype:
The concept that distinct communities of bacteria are defined
by their bacterial composition (Arumugam et al., 2011)
Metabonomics:
The quantitative measurement of the multiparametric (timerelated) metabolic responses of complex systems to a
pathophysiological stimulus or genetic modification (Nicholson
et al., 1999); often used synonymously with metabolomics
(Fiehn, 2002)
Metagenomics:
The study of the gene content and encoded functional
attributes of the gut microbiome in healthy humans (Gill et al.,
2006)
Microbiome (human): The full complement of microbes (bacteria, viruses, fungi,
and protozoa), their genes, and genomes in or on the human
body
Prebiotic:
A substance that (1) is resistant to gastric acidity, to enzymatic
hydrolysis, and to gastrointestinal absorption (i.e., not
hydrolytically digestible); (2) is fermented by cecal-colonic
microflora; and (3) selectively stimulates growth and/ or
activity of those bacteria that contribute to colonic and host
health (Gibson et al., 2004) or a nonviable food component
that confers a health benefit on the host associated with
modulation of the microbiota (Pineiro et al., 2008)
Probiotics:
Living microorganisms that, when administered in adequate
amounts, confer a health benefit on their host (FAO-WHO,
2002)
Resistome:
The collective informational resources available to the
microbiome for responding to antimicrobial pressure (Wright,
2007)
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Microbiome-derived

recommendations

for

Precision

Nutrition:

A

Primer

As defined in the table above, the microbiome is the collective complement of microbes
(bacteria, viruses, fungi, and protozoa), their genes, and genomes in or on the human body.
Emerging research ties functions of the microbiome to variable aspects of health and disease.
The microbiome is influenced by food, and food influences the microbiome. There is an
interesting interaction between nutrition and dietary patterns and microbiome fluctuations that
scientists are trying to unravel. Given the individualistic nature of each person’s microbiome, it
has emerged as an important factor to consider in precision nutrition. Microbiome testing, where
fecal samples are evaluated, is another layer of testing to provide individualized information that
might influence precision nutrition recommendations. As outlined below, this concept of using
microbiome-centric data to predict physiological outcomes due to diet depends on the
acquisition and analysis of data.
Figure 3.2 below illustrates the concept of human study participants adopting a dietary
intervention and then undergoing microbiome analysis, with these data being parsed out
according to a response. Data from responders and non-responders would be analyzed with the
goal to correlate cause and effect. Computational tools would then be utilized to translate data
points into algorithms which may predict responsiveness to a diet.
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Figure 3.2 Microbiome data modeling for precision nutrition; from Mills et al. 2019.

Challenges and Special Considerations for Precision Nutrition
Precision nutrition is not universally adopted because of a myriad of challenges including
financial, ethical, and logistical--not to mention scientific. There is a lack of well-designed clinical
trials showing consistent results, and expensive technologies are required to collect and study an
individual’s DNA, gut microbiome, and response to food intake. The ethical and legal aspects of
implementing precision nutrition should also be considered, including protecting consumer
privacy in the use of precision nutrition technologies and tests. Further, if personalized
approaches are accessible to only a small segment of the population this can further widen health
disparities.
The path forward for precision nutrition must integrate diverse disciplines in an intentional
manner that will be usable and applicable for a diverse cohort of patients, even though each of
these patients will have unique and distinct recommendations. The International Society of
Nutrigenetics/Nutrigenomics identifies the following items as imminent and future challenges to
the field of precision nutrition.
Table 3.5 Imminent and future challenges for precision nutrition
Strengthening precision nutrition science
Creation of risk map
Creation of a reliable “bank” of polymorphisms
Tests of epigenetic assessment
Identifying valid biomarkers
Microbiome, lipidomic, proteomic studies
Implementation of public health policies
Development of innovative technologies for analyzing, synthesizing, integrating data
Applicability and integration with clinical practice
Tools for evaluating diet
Regulation of ethical and legal aspects
Cost reduction
Training personnel and improving knowledge delivery
Increase availability of trained allied health professionals capable of interpreting
genetic data
Increase involvement of dietetic professionals in dietary recommendations
Promote introduction of nutrigenomic education into the curricula of allied health
professionals and within medical curricula
Public education
Communication with and involvement of science writers
Dissemination of “lay” information via mainstream media in the form of print, screen,
and social media

24

Precision Nutrition & Advanced Culinary Medicine E-Book
Module 4

Sara B. Police, PhD
Assistant Professor, Department of Pharmacology and Nutritional Sciences
University of Kentucky College of Medicine

Chapter 4/Module 4: Table of Contents
Content
- CVD and Precision
Nutrition
-

Metabolic Syndrome

-

Dietary Patterns
o DASH
o Mediterranean Diet
o Intermittent Fasting
(IF)

Resources
Personalized Nutrition As Medical Therapy for High-Risk Diseases,
edited by Nilanjana Maulik, Taylor & Francis Group, 2020. ProQuest
Ebook Central, http://ebookcentral.proquest.com/lib/kentuckyebooks/detail.action?docID=6182012

Guembe, M.J., Fernandez-Lazaro, C.I., Sayon-Orea, C. et al. Risk for
cardiovascular disease associated with metabolic syndrome and its
components: a 13-year prospective study in the RIVANA
cohort. Cardiovasc Diabetol 19, 195 (2020).
https://doi.org/10.1186/s12933-020-01166-6

Anderson, J.J.B., & Sparling, M.C. (2014). The Mediterranean Way of
Eating: Evidence for Chronic Disease Prevention and Weight
Management (1st ed.). CRC Press. https://doi.org/10.1201/b17032

Castro-Barquero S, Ruiz-León AM, Sierra-Pérez M, Estruch R, Casas R.
Dietary Strategies for Metabolic Syndrome: A Comprehensive
Review. Nutrients. 2020; 12(10):2983.
https://doi.org/10.3390/nu12102983
Albosta, Michael, and Jesse Bakke. “Intermittent Fasting: Is There a
Role in the Treatment of Diabetes? A Review of the Literature and
Guide for Primary Care Physicians.” Clinical diabetes and
endocrinology 7.1 (2021): 3–3. Web.
https://saalckuky.primo.exlibrisgroup.com/permalink/01SAA_UKY/ija67f/cdi_doaj_p
rimary_oai_doaj_org_article_4499d104150640e2984678a12ff6ae21
Rynders, Corey A et al. “Effectiveness of Intermittent Fasting and TimeRestricted Feeding Compared to Continuous Energy Restriction for
Weight Loss.” Nutrients 11.10 (2019): 2442–. Web.
https://saalckuky.primo.exlibrisgroup.com/permalink/01SAA_UKY/ija67f/cdi_doaj_p
rimary_oai_doaj_org_article_22ce3704c9594b878516e0e599575d14

2

Cardiovascular Disease (CVD) and Principles of Precision Nutrition
Cardiovascular disease (CVD) was the leading cause of death globally in 2017 and is associated with
numerous risk factors including obesity/diabetes, metabolic dyslipidemia, hypertension, insulin
resistance, lack of physical activity, smoking and alcohol consumption (Turner, Millns et al. 1998; Mackay
and Mensah 2004). Many of these same risk factors comprise diagnosis of the Metabolic Syndrome
(discussed later). It is estimated that nearly 18 million people died from CVD in 2015, equating to ~30% of
all global deaths. CVDs are a group of disorders of the heart and blood vessels and include coronary heart
disease (CHD), cerebrovascular disease, peripheral arterial disease, rheumatic heart disease, congenital
heart disease, deep vein thrombosis and pulmonary embolisms (2017). In developed countries including
North America, Europe, and Australia, at least one-third of all CVD is attributable to five lifestylemodifiable risk factors: tobacco use, alcohol use, high blood pressure (BP), high cholesterol and obesity
(Mackay and Mensah 2004). Precision Nutrition (PN) has been defined by Gibney and Goosens as an
approach that assists individuals in achieving a lasting dietary behavior change that is beneficial for health
(Gibney and Goosens 2016). According to these authors, there are at least three levels to PN (PN1– 3)
increasing in complexity and individualization and, in turn, feasibility to implement (Gibney and Walsh
2013).
Precision Nutrition Level 1 - PN1 has seen widespread success using technology to record and analyze
imputed food intake and physical activity levels and provide tailored advice to the end-user to improve
health (Gibney and Walsh 2013). There is a multitude of software applications available that have
transformed PN1 from an ideological concept that could only be accessed by those with the means, to
widespread dissemination to anyone with access to mobile phone technology and an interest in PN for
health. In terms of PN in the management of CVD, PN1 certainly provides a means to educate patients on
implementation and adherence to a healthy diet, which is a critical lifestyle-modifiable factor that can
profoundly reduce CVD risk.
Precision Nutrition Level 2 - PN2 involves tailoring nutritional advice based on a person’s
phenotype/metabotype. In the management of CVD, nutrition can and should be tailored to manage
nutrient-modifiable risk factors such as weight, blood pressure, sodium intake and lipoprotein profiles as
appropriate to the individual. There is growing interest in the use of dried blood spots (DBS) in PN2 to
derive biochemical/metabolic profiles of individuals and adapt a diet according to these parameters (Celis
Morales, Livingstone et al. 2015). The feasibility of using DBS in a large population, using blood samples
taken remotely, to direct PN has recently been established in the European Union Seventh Framework
Programme integrated project, Food4Me (Celis-Morales, Livingstone et al. 2015). This study analyzed a
wide variety of biochemical measurements from DBS including glucose, total cholesterol, carotenoids,
omega-3 (n-3) fatty acid index, fatty acids, and vitamin D (Celis-Morales, Livingstone et al. 2015). DBS can
also be used for lipidomic (Gao, McDaniel et al. 2017), metabolomic (Wang, Sun et al. 2016) and proteomic
(Martin, Bunch et al. 2013) analyses and thus a vast amount of data can be derived from a small sample
size. Indeed, the expansive information that is acquired from DBS, using more sensitive analytical
platforms, provides the power to group individuals into metabotypes wherein individuals are grouped
into clusters with similar metabolic profiles (Gibney and Goosens 2016). Metabotype subgroups may
respond differently to nutrients contributing to interindividual variability that exists during nutrition
interventions. A recent study, for example, hypothesized that the interindividual variability to the lipid
lowering properties of pomegranate may be due to variability in polyphenol metabolism (GonzalezSarrias, Garcia-Villalba et al. 2017). Participants were grouped according to the microbially derived
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ellagitannin-metabolizing phenotypes including urolithin metabotypes A, B and 0 (UM-A, UM-B and UM0). The UM-B cluster exhibited the greatest CVD risk at baseline but also exhibited the greatest lipidlowering response to phenolics (Gonzalez-Sarrias, Garcia-Villalba et al. 2017). This is a prime example of
how PN may be implemented to prescribe the right diet to the right responder and move away from a
one-size-fits-all approach to nutrition.

Precision Nutrition Level 3 - PN3 involves tailoring nutritional advice to a person’s genotype. This is the
premium level for PN and the most challenging to implement. In the era of genome-wide association
studies (GWAS) and post-the Human Genome Project, it has been widely envisioned that both
personalized medicine and PN would be based on the ultimate blueprint of a person, their genetic code
(Gibney and Walsh 2013). One of the first single nucleotide polymorphisms (SNPs) to be identified that
contributes to dysbetalipoproteinemia was in the Apolipoprotein (Apo) E gene which resulted in
accumulation of triglyceride (TG)-rich lipoproteins in circulation (Utermann, Hees et al. 1977). There are
three common isoforms of ApoE (ApoE2, ApoE3 and ApoE4) that are encoded by a gene on chromosome
19— 55– 60% of individuals are homozygous for the E3 allele (Davignon, Gregg et al. 1988; Minihane,
Khan et al. 2000). Individuals carrying the ApoE4 allele have the highest levels of low-density lipoprotein
(LDL)-cholesterol and ApoB, intermediate levels are observed in individuals homozygous for ApoE3, and
the lowest levels are evident in those with the ApoE2 allele (Davignon, Gregg et al. 1988). Individuals with
the ApoE2 allele also display reduced postprandial TG response to fish-oil intervention relative to non-E2
carriers, indicative of better response to fish-oils in individuals with this genotype (Minihane, Khan et al.
2000). This is one example of how dietary advice could be tailored to genotype. Those individuals with the
ApoE2 allele should be encouraged to consume fish-oil enriched diets due to their propensity to yield
beneficial effects from these nutrients.
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Metabolic Syndrome
Excerpts adapted from:
•

•

•

Personalized Nutrition As Medical Therapy for High-Risk Diseases, edited by Nilanjana Maulik, Taylor &
Francis Group, 2020. ProQuest Ebook Central, http://ebookcentral.proquest.com/lib/kentuckyebooks/detail.action?docID=6182012
Guembe, M.J., Fernandez-Lazaro, C.I., Sayon-Orea, C. et al. Risk for cardiovascular disease associated with
metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc
Diabetol 19, 195 (2020). https://doi.org/10.1186/s12933-020-01166-6
Anderson, J.J.B., & Sparling, M.C. (2014). The Mediterranean Way of Eating: Evidence for Chronic Disease
Prevention and Weight Management (1st ed.). CRC Press. https://doi.org/10.1201/b17032

The Metabolic Syndrome (MetS) refers to a constellation of interrelated risk factors that place an
individual at high risk of developing CVD and type II diabetes. MetS is defined as a clustering of metabolic
risk factors; a diagnosis is generally made when 3 or more of the following criteria are met (Anderson,
Sparling 2014):
1.
2.
3.
4.

Abdominal obesity: waist circumference of at least 40 inches in men or 35 inches in women
Hypertriglyceridemia: triglyceride level of at least 150 mg/dL
Low HDL cholesterol: less than 40 mg/DL in men or less than 50 mg/dL in women
Hypertension: defined by systolic blood pressure of at least 130 mm Hg or diastolic blood pressure
of at least 85 mm Hg
5. Hyperglycemia: fasting blood glucose level of at least 100 mg per dL.

As mentioned above, a diagnosis of MetS is associated with elevated risk for developing cardiovascular
diseases. In fact, individuals diagnosed with MetS have a 2-fold increased risk of CVD, mortality due to
CVD, and stroke, and a 1.5-fold increased risk of all-cause mortality associated with MetS (Guembe, 2020).
The precise mechanisms underlying complex pathways of MetS are under investigation; however, it is
understood that one’s dietary patterns can contribute to the development of MetS. Weight gain and
obesity, particularly elevated levels of visceral adiposity, contribute to hyperglycemia and hypertension
(Maulik). Since a singular dietary recommendation and/or regimen can yield different outcomes from
person to person, it would be helpful for practitioners to predict which dietary pattern could be most
helpful for any patient (in other words, to utilize personalized or precision nutrition).
GENETICS & METABOLIC SYNDROME
The intricate link between multiple lifestyle-associated risk factors and cardiovascular disease (CVD)
indicates the importance of maintaining a healthy diet for CVD management; but there is also an
irrefutable genetic component to CVD (Khera and Kathiresan 2017). Clinical observation from the 1950s
have supported the opinion that CVD is heritable (Gertler, Garn et al. 1951). A study of ~20,000 twins in
Sweden confirmed this and showed increased CVD risk for those with close relatives affected by the
disease and estimated that heritable factors account for 30– 60% of the interindividual variation in CVD
risk (Marenberg, Risch et al. 1994; Zdravkovic, Wienke et al. 2002). The Framingham Heart Study similarly
showed that having a parent or sibling with CVD was a strong predictor of the incidence of disease (LloydJones, Nam et al. 2004; Murabito, Nam et al. 2004). However, at the time of this resource publication, it
is poorly understood whether poor lifestyle further exacerbates CVD in high-risk individuals. In updated
genome-wide association studies (GWAS), it is estimated that heritability of CVD is 40– 50% (Won,
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Natarajan et al. 2015). Many researchers once assumed that genetic predisposition is deterministic (White
1957), but in fact an individual’s risk of developing CVD is a dynamic interplay between genetic and
lifestyle factors (Khera, Emdin et al. 2016). Thus, lifestyle may accentuate genetic susceptibility, or not.
A cornerstone study by Khera et al. investigated to what extent increased genetic risk can be offset by
healthy lifestyle (Khera, Emdin et al. 2016). The study involved over 55,000 participants across 3
prospective cohorts where adherence to healthy lifestyle was determined by using a scoring system
consisting of 4 factors: 1. no smoking, 2. no obesity (BMI < 30), 3. physical activity at least once weekly
and 4. consumption of a healthy diet. The polygenic risk score was derived from analysis of 50 SNPs that
achieved genome-wide significance for association with CVD (Consortium, Deloukas et al. 2013). A healthy
diet pattern was determined based on adherence to at least half of the following items (Mozaffarian
2016); high consumption of fruits, nuts, vegetables, whole grains, fish and dairy products and low intake
of
refined
carbohydrates,
processed
meats.
PROOF OF CONCEPT FROM LIPGENE
There is major potential for nutrition research and primary care to use genome-wide association study
(GWAS) data for more in-depth PN approaches to treat CVD; however, there are multiple hurdles that
must be overcome to translate this into a clinical reality. A greater understanding of potential genenutrient interactions on newly identified SNPs is essential to implement PN3, and therefore much research
is required in this field. Gene-nutrient interactions and implications for CVD have been comprehensively
reviewed by Corella et al. (Corella, Coltell et al. 2017). A proof-of-concept study that has explored dietnutrient interactions in patients with the metabolic syndrome was the pan-European LIPGENE study.
LIPGENE was a multicenter, single-blind, randomized controlled trial that aimed to 1) determine the effect
of reducing saturated fatty acid (SFA) consumption by altering quality of dietary fat and reducing quantity
of dietary fat on the metabolic syndrome and its associated risk factors; and 2) determine if common
genetic polymorphisms affect an individual’s responsiveness to dietary therapy. The study included eight
European centers and nearly 500 volunteers who were diagnosed with the metabolic syndrome; they
were assigned to one of four dietary interventions:
1)
2)
3)
4)

high-fat (38% energy) SFA-rich diet
high-fat (38% energy) mono-unsaturated fatty acid (MUFA)-rich diet
isocaloric low-fat (28% energy), high complex carbohydrate diet
isocaloric low-fat (28% energy), high complex carbohydrate diet with 1g/d LC n-3 PUFA for 12
weeks (Shaw, Tierney et al. 2009; Tierney, McMonagle et al. 2011).

LIPGENE attempted to use genotype information of individuals to investigate responsiveness of singular
SNPs to dietary fat on markers of the metabolic syndrome. For example, individuals with the minor allele
at rs1799983 in the nitric oxide synthase 3 (NOS3) gene were shown to have a greater TG-lowering
response to n-3 PUFA than major allele carriers (Ferguson, Phillips et al. 2010). Individuals with this
genotype in turn were projected to yield the greatest benefit from increasing PUFA intake. By contrast,
individuals with the minor alleles of rs266729 and rs10920533 SNPs in ADIPOQ and in ADIPOR1 were
particularly sensitive to insulin resistance in response to SFA consumption (Ferguson, Phillips et al. 2010).
It was therefore speculated that individuals carrying these minor alleles would be particularly responsive
to SFA lowering to improve insulin sensitivity. These findings are excellent proof of concept of how PN3
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might be realized. However, a lot of SNPs studied in previous nutrigenomic studies have not been
validated in recent GWAS for CVD and go beyond the scope of this eBook.
Implementation of PN1 for the management of CVD depends on understanding of the optimal diet for the
management of CVD. The current recommended dietary guidelines for CVD management include
consuming a diet rich in fruits and vegetables, grains, low-fat or non-fat dairy products, fish, legumes,
poultry, and lean meats (Krauss, Eckel et al. 2000; Eckel, Jakicic et al. 2014). In turn, recommendations are
sub-divided into guidelines for body weight (match energy intake to energy needs), cholesterol profiles
(limit foods high in saturated fat and cholesterol; and substitute unsaturated fats from vegetables, fish,
legumes, and nuts), and blood-pressure management (limit salt and alcohol, maintain a healthy body
weight, increase intake of vegetables, fruits, and low-fat/non-fat dairy products). Dietary patterns with an
evidence base demonstrating efficacy toward the prevention, mitigation, or treatment of MetS included
within this text are DASH (Dietary Approaches to Stop Hypertension), the Mediterranean Diet, and
Intermittent Fasting.
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Dietary Patterns
a. Dietary Approaches to Stop Hypertension (DASH)
Excerpts adapted from:
•

Castro-Barquero S, Ruiz-León AM, Sierra-Pérez M, Estruch R, Casas R. Dietary Strategies for Metabolic
Syndrome: A Comprehensive Review. Nutrients. 2020; 12(10):2983. https://doi.org/10.3390/nu12102983

In 1997, the Dietary Approaches to Stop Hypertension (DASH) diet became a promising strategy for the
treatment of high blood pressure, and subsequent randomized clinical trials (RCTs) have supported this
evidence. This eating pattern promotes vegetables, fruits, whole grains, low- or free-fat dairy products,
legumes, and nuts intake, while restricting the intake of red and processed meat and sugar-sweetened
beverages. The DASH diet is characterized by a low-fat content (27% of daily calorie intake from fat),
especially saturated fats (6% of energy or less) and dietary cholesterol (150 mg per day or less,
approximately), and reduced sodium content (from 1500 to 2300 mg/day), but it is rich in fiber (>30
g/day), potassium, magnesium, and calcium compared to other dietary patterns. The DASH diet has
proven to be a useful strategy for the treatment of hypertension, and several epidemiological studies have
associated higher adherence to the DASH diet with a better cardiometabolic profile. In a meta-analysis of
several cohort studies, Schwingshackl et al. reported that higher adherence to the DASH diet was
associated with a significant reduction in the risk of all-cause mortality, the incidence of or mortality by
CVD and cancer, and the incidence of Type 2 Diabetes Mellitus (T2DM).
Epidemiological evidence suggests an association between higher adherence to the DASH diet and a
better cardiometabolic profile and reduced risk of CVD. Increased adherence to the DASH diet was
associated with 48% less risk of developing MetS. In contrast, body mass index (BMI), waist circumference,
pro-inflammatory markers, and adiposity measures were significantly lower compared to individuals with
lower adherence to the diet.
The DASH diet is highly nutritious, with a stress on consumption of vegetables and fruits, which translate
into higher potassium, magnesium, and fiber intake – all which have shown a role in BP control, glucose
metabolism, and insulin response. Moreover, limiting sodium and fat – chiefly saturated fat – is a double
benefit. Research demonstrates that patients who are committed to adherence will benefit from reduced
risk for CVD.

Figure 4.1. The DASH dietary pattern emphasizes
vegetables, fruits, and whole grains with limits on
sodium, sweets, and meats (even lean cuts).
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b. Mediterranean diet approach (Almudena Sanchez-Villegas)
The Mediterranean diet is a well-known and recognized dietary pattern. There is substantial scientific
evidence backing the efficacy of the Mediterranean diet to reduce risk for various chronic diseases,
including hypercholesterolemia, hypertension, and insulin resistance--all facets of the MetS. Multiple
observational studies and clinical trials have demonstrated favorable outcomes associated with adopting
the Mediterranean diet. A few examples of evidence along these lines include:
-

The SUN (Seguimiento Universidad de Navarra) study. A Spanish prospective cohort study based on
university graduates that followed 3,609 participants (initially free of cardiovascular disease) for 4.9
years. Participants of the SUN study with the highest adherence to the Mediterranean Diet (a score
>6, as measured by the Mediterranean Diet Score, or MDS) exhibited a lower cardiovascular risk
(significant risk reduction = 59%) compared to those with the lowest adherence score (<3). For each
2-point increment in the score, the adjusted relative reduction in risk was 20% for total cardiovascular
disease and 26% for coronary artery disease (CAD).

-

The EPIC study (European Prospective Investigation into Cancer and Nutrition) is one of the largest
cohort studies in the world, with more than 500,000 participants recruited across 10 countries and
followed for 15 years. This study sought to determine the relation between Mediterranean Diet
adherence and risk of incident coronary heart disease events in the five Spanish centers of the EPIC
study. After following up to 41,078 participants for about 10 years, the researchers found that high
compared with low relative Mediterranean Diet adherence was associated with a significant reduction
in coronary heart disease risk (relative risk reduction of 40%, 95% confidence interval = 23-53%). A 1unit increase in relative Mediterranean Diet score was associated with a significant reduction in the
risk (6%). In other words, for both the SUN and EPIC studies, the more closely that participants
followed the Mediterranean diet, the lower their relative risk for developing cardiovascular disease.

-

A landmark trial that examined the efficacy of two variations of the Mediterranean diet is the
PREDIMED trial. PREDIMED trial was a parallel-group, multicenter, randomized trial that compared
the outcomes of adhering to a Mediterranean diet supplemented with extra-virgin olive oil (EVOO)
versus a Mediterranean diet supplemented with nuts, versus a control diet (the group was advised to
lower dietary fat). There was almost a 5-year follow-up with this trial, but it ended earlier than planned
due to interim analysis. The data indicated that the control group participants were experiencing a
significantly higher frequency of CVD events and CVD-associated mortality compared to the two diet
groups who were consuming the Mediterranean diet (regardless of whether it was supplemented
with mixed nuts or extra virgin olive oil).

Mediterranean patterns of eating are representative of the most beneficial diets known to humankind.
Because they included so many plant foods, including fruits, vegetables, legumes, whole grains, nuts, and
seeds, they historically provided just enough calories each day to meet the needs of energy expenditure
in daily activities. The major benefit in terms of calories was that individuals did not become obese, as
occurs so frequently now in the United States and many other nations. So, calorie control was built into
the typical eating pattern with little other constraint on food intake needed.
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Adherence to a Mediterranean dietary pattern has been demonstrated to improve health and reduce
mortality from many chronic diseases, especially cardiovascular diseases, type 2 diabetes mellitus, and
diet-related cancers. Chronic disease rates are generally lower in Mediterranean populations than in other
Western nations (Anderson, Sparling 2014 “The Med Way of Eating”).
Are there aspects of the Med Diet that work for some, but not others? What elements need evaluation
with a precision nutrition lens? How can we tweak this diet for each patient cohort? These are some of
the questions to consider regarding positioning of the Mediterranean diet within precision medicine.
Table 4.1 Common foods within the traditional diet of Mediterranean countries (Almudena Sanchez-Villegas)

Foods
Veg &
fruits
Grains

Olives and
olive oil

Nuts,
legumes,
seeds
Fish and
shellfish

Cheese
and yogurt
Meat
Wine

Herbs and
spices

Description
Vegetables and fruits are important sources of minerals, vitamins, antioxidants, and
fiber. Benefits of their consumption are amplified if they are cooked or dressed with
olive oil.
The nutritional composition of grains may vary depending on the variety and
environmental growing conditions. In general, cereal grains are high in carbohydrates,
low in fat, good sources of protein and provide varying amounts of fiber, vitamins, and
minerals. Cereal products should contain whole grains, including wheat, oats, rice, rye,
barley, and corn. Grains should also be consumed in minimally processed forms.
Olive oil is a central component in the cuisine of the countries surrounding the
Mediterranean Sea. This type of vegetable oil has a peculiar fatty acid composition
(with a large proportion of monounsaturated fat—mainly oleic acid—and a relatively
low proportion of saturated fat) and contains other minor compounds (tocopherols
and carotenoids among others) with antioxidant properties. Olive oil is the principal
source of dietary fat in the Mediterranean Diet and is frequently used to dress salads
and vegetables, and in cooking or baking. The variety “extra-virgin” olive oil is highest
in health promoting fats, phytonutrients, and other important micronutrients.
Nuts, legumes, and seeds are packed with vitamins and minerals. Nuts and seeds also
provide healthy mono- and polyunsaturated plant oils as well as protein. Legumes,
which include beans, are filling and contain lean protein.
Fish and shellfish are preferred over meat in the traditional Mediterranean diet,
although the quantity of fish consumed varies widely between and within
Mediterranean countries. Fish and shellfish are an important source of healthy protein
and essential heart-healthy omega-3 fatty acids.
Dairy products from a variety of animals including goats and sheep, principally in the
form of yogurt and cheese, are consumed in low to moderate amounts.
Consumption of red meat and processed meats is lower in the Mediterranean
population than the consumption of white meat.
Moderate wine drinking in the context of the meals has been a long-standing tradition
in the Mediterranean basin, except for Islamic populations of this area. “Moderate”
generally refers to one glass per day for women, and two glasses for men.
Herbs and spices add flavors and aromas to foods, reducing at the same time the need
to add salt or fat when cooking. Herbs and spices are very common in Mediterranean
cuisine; they contain several health-promoting antioxidants and contribute to the
differences between the broad varieties of culinary cultures.
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c. Intermittent Fasting, Weight Management & Metabolic Syndrome
Excerpts adapted from:
•

Albosta, Michael, and Jesse Bakke. “Intermittent Fasting: Is There a Role in the Treatment of Diabetes? A
Review of the Literature and Guide for Primary Care Physicians.” Clinical diabetes and endocrinology 7.1
(2021): 3–3. Web: https://saalckuky.primo.exlibrisgroup.com/permalink/01SAA_UKY/ija67f/cdi_doaj_primary_oai_doaj_org_article_4499
d104150640e2984678a12ff6ae21

INTERMITTENT FASTING
Intermittent fasting has recently gained popularity as a means of improving body composition and
metabolic health [28, 29]. Intermittent fasting (IF) refers to eating patterns based around the principle of
consuming very little to no calories for time periods ranging from 12 hours to several days with a regular
and consistent pattern [28]. With IF, more emphasis is placed on when eating takes place, as opposed to
what is eaten at any given time. There are several different types of IF in theory and practice. One such
regimen is alternate day fasting, in which days of fasting are separated by days of ad libitum feeding [29].
Another method is periodic fasting, in which individuals fast for 1 or 2 days a week (also referred to as 5:2
or 6:1 fasting) [29]. Finally, the most common method is time-restricted feeding (TRF), in which food
consumption is only allowed during a specified window of time each day, typically with 16–20 h daily fasts
[29].
It has long been known that restricting calories can lead to weight loss. A study by Larson-Meyer et al.
[34] showed that 25% calorie reduction either via diet alone or diet in conjunction with exercise led to
improvements in insulin sensitivity and reduction in β-cell sensitivity in overweight, glucose-tolerant
individuals. However, several obesity trials have demonstrated that humans have significant difficulty
sustaining daily calorie restriction for extended periods of time [28]. On the other hand, IF has higher
compliance and has shown promise in the improvement of metabolic risk factors, body composition, and
weight loss in obese individuals [28, 35, 36]. It has been shown that these beneficial effects are due in part
to the shift during fasting from the utilization of glucose to fatty acids and ketones as the body’s preferred
fuel source [28]. During this transition the body begins to switch from the synthesis and storage of lipids
to mobilization of fat in the form of ketone bodies and free fatty acids [28]. This transition of fuel source,
or metabolic reprogramming, has been highlighted as a potential mechanism for many of IF’s beneficial
effects. Interestingly, the research studies examining IF have demonstrated multifarious health benefits
outside of weight loss, such as improved sleep, decreased brain fog (improved cognition), improved insulin
sensitivity, among others. Further, IF has been shown to reduce adiposity, particularly visceral fat, and
truncal fat, largely due to mild energy deficits [12, 17]. It is through this reduction in adiposity that patients
may experience improvements in their leptin/adiponectin levels and sensitivity, leading to improved
appetite control and lower levels of chronic inflammation thus improving several risk factors for type 2
diabetes.
It is the development of insulin resistance, which is defined as the necessity of higher circulating insulin
levels to produce a glucose lowering response, that is thought to be responsible for the development of
type 2 diabetes [7]. To promote regulation of glucose homeostasis, insulin works primarily on receptors
in skeletal muscle, liver, and white adipose tissue [7]. In short, there are several proposed mechanisms
regarding the development of insulin resistance. One of the more prominent theories describes the
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association of increased adiposity and the subsequent chronic inflammation that leads to the
development of insulin resistance in tissues [7].
IF may reduce adiposity and subsequently insulin resistance via reduction of caloric intake as well as due
to metabolic reprogramming. In addition, energy/nutrient depletion (such as that achieved through
reduced caloric intake) has been shown to promote healthier aging and reduction in chronic disease
through increased activation of AMP activated protein kinase (AMPK) [37]. AMPK responds both to
increased AMP/ADP:ATP ratios as well as to endocrine signals of hunger and satiety [37]. The role of AMPK
at a biochemical level is outside of the scope of this review; however, activation of AMPK through a low
energy state has been shown to initiate physiologic responses that promote healthy aging [37]. Increased
levels of insulin, whether through increased energy intake or insulin resistance, leads to the activation of
downstream mediators that ultimately inhibit AMPK. The role of AMPK in improved insulin sensitivity is
most evident via the positive effects of the commonly prescribed biguanide, metformin. Metformin is
known to promote the activation of AMPK and has been shown to be very effective in the treatment of
type 2 diabetes as well as in the mitigation of several chronic disease states [37]. In theory, decreased
energy intake, such as that achieved through intermittent fasting, will lead to prolonged decreased levels
of insulin production and increased levels of AMPK, which likely plays a role in the improvements in insulin
sensitivity and glucose homeostasis.
INTERMITTENT FASTING AS A TREATMENT OPTION FOR TYPE 2 DIABETES
Several studies have shown promise for the use of IF protocols as a potential treatment for diabetes. In a
systematic review and meta-analysis by Cho et al. [32] that included studies evaluating patients both with
and without pre-diabetes (diabetic patients were excluded), it was found that of 8 studies comparing the
effects of an intermittent fasting diet to a control group, BMI decreased by 0.75 kg/m2 over periods
ranging from 4 to 24 weeks. Furthermore, of 8 studies comparing intermittent fasting to a control group
in the evaluation of glycemic control, it was found that the intermittent fasting group had significant
reductions in fasting glucose levels (− 4.16 mg/dL; p = 0.003). Lastly, when comparing leptin and
adiponectin levels between the intermittent fasting subjects and the control subjects in all studies, the
reviewers found increased adiponectin levels (1008.87 ng/mL; p = 0.023) and decreased leptin
(− 0.51 ng/mL; p < 0.001) [32]. A case series by Furmli et al. [26] followed three patients with type 2
diabetes over several months after beginning an intermittent fasting regimen consisting of three, 24 h
fasts per week. Over the course of the study, all patients had significant reductions in HbA1C, weight loss,
and all the patients were able to stop their insulin therapy within 1 month [26]. Interestingly, the three
patients in this case series all reported tolerating fasting very well, and no patient stopped the
intervention at any point out of choice [26]. This suggests that intermittent fasting may not only be
successful as a non-medicinal treatment option for patients with type 2 diabetes but supports the notion
that this intervention is tolerable as well. Carter et al. [19] performed a clinical trial in which 137 adults
with type 2 diabetes were divided into two groups, one intermittent energy restriction group (500–
600 kcal/day for 2 days per week and normal diet every other day) and a continuous energy restriction
group (1200–1500 kcal/day). After 12 months of intervention, the two groups showed similar reductions
in HbA1C levels and greater reductions in weight in the intermittent energy restriction group. Finally, a
similar clinical trial by Gabel et al. [16] compared an alternate day fasting regimen (25% of energy needs
on fasting days, 125% of energy needs on non-fasting days) to continuous energy restriction (75% of
energy needs daily) and a control group of obese, non-diabetic patients. Over an intervention period of
12 months, there were similar reductions in body weight, BMI, and fat mass between the alternate day
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fasting and continuous energy restriction groups, however there were significant reductions in fasting
insulin levels (− 44%; p < 0.05) and homeostatic model assessment of insulin resistance (HOMA-IR) levels
(− 53%; p < 0.05) in the alternate day fasting group [16]. HOMA-IR is a marker used to measure levels of
insulin resistance.
PRESCRIBING INTERMITTENT FASTING IN PRACTICE: RECOMMENDATIONS
While alternate day fasting and periodic fasting have demonstrated efficacy in improving metabolic risk
factors, it may be difficult to convince patients to give up or severely restrict calories for an entire 24 h
period. In America, we often eat 3 meals per day in addition to frequent snacking. Furthermore, in
American culture most social engagements involve food. Asking patients to eliminate these experiences
from their day-to-day lives may become burdensome, and thus hinder patient compliance. Finally,
patients switching to an intermittent fasting regimen may initially experience symptoms such as hunger
and irritability, although these symptoms often dissipate within the first 30 days [38]. Therefore, it would
be more appropriate to gradually introduce intermittent fasting in the form of time restricted feeding. For
example, clinicians may first recommend that patients restrict their intake to a daily 12 h period, typically
an overnight fast (for example, 7 pm to 7 am). As patients become more comfortable with this pattern of
eating, the feeding window can be restricted further (16 h fast followed by an 8 h feed or 20 h fast
followed by a 4 h feed). This allows the patient some daily flexibility in choosing when to consume calories,
thus increasing the likelihood of compliance. Lastly, patients who have become adapted to time restricted
feeding may choose to switch to alternate day or periodic fasting with the supervision and guidance of a
registered dietician. See Fig. 5 for a detailed example of an intermittent fasting prescription.
PRESCRIBING INTERMITTENT FASTING IN PRACTICE: CONSIDERATIONS
When considering the use of fasting in patients with diabetes, several points should be weighed. First, it
is important to discuss potential safety risks associated with fasting. Patients taking insulin or sulfonylurea
medications should be closely monitored by their healthcare provider to prevent hypoglycemic events
[39]. Because studies are demonstrating a decreased need for insulin in patients who follow IF protocols,
blood glucose levels and medication titration should be observed closely by the physician. Physicians
should help patients make appropriate adjustments to their medications, especially on days of fasting.
Physicians may choose to have patients keep daily blood sugar and weight logs and send them weekly or
biweekly via electronic message to assist providers in medication titration over time. Of note, while the
goal of adapting this pattern of eating is to reduce or eliminate the need for medications, including insulin,
there are situations in which insulin may be necessary, such as severe hyperglycemia. Failure to do so may
result in significant consequences, such as the development of hyperosmolar hyperglycemic syndrome.
Additional concerns, although unlikely, include vitamin and mineral deficiencies and protein malnutrition
[39]. Patients should be educated regarding the importance of consuming nutrient-rich meals and
adequate protein intake during feeding periods. Furthermore, it may be important to consider vitamin or
mineral supplementation depending on the patient’s dietary practices and the desired length of a fasting
regimen. Patients should also be counseled on the need for adequate hydration during periods of fasting,
as they will be required to replace fluids that might normally be consumed through food in addition to
regular daily requirements. As many physicians may not be trained extensively in nutritional sciences, and
further, may not have time to follow daily with patients to ensure appropriate nutritional intake,
consultation with a registered dietitian is highly recommended. Lastly, it is important to consider
populations in whom fasting may not be appropriate. These include pregnant/lactating women, adults of
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advanced age, individuals with immunodeficiencies, individuals with hypoglycemic events, and patients
who suffer from eating disorders [39].
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Introduction
In a pandemic and post-pandemic era, the spotlight on mental health and decreasing existing stigmas
about mental health has been at an all-time brightness. Any role for nutrition and food within neurological
and mental health management can be a heavy and controversial topic, especially depending on who is a
part of the conversation. Research is ongoing in this field, but much groundwork has been established at
the time this chapter was written and compiled.
For example, studies have shown that individuals who consume higher quality diets are at reduced risk
for incidence of depression. The key point here being reduced risk, not to be protected from. Further,
specific medical and prescriptive diets have been shown clearly to be efficacious for extremely specific
mental health conditions, such as epilepsy. The ketogenic diet and research supporting its use in
intractable epilepsy are discussed here. Dementia and Alzheimer's Disease are increasing in case numbers
and concern as an aging population grows older, lives longer, and becomes at increased risk of developing
either. These patients can suffer with dysphagia, which is a risk for malnutrition. Information describing
evidence-based dietary approaches for this population are also discussed.
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Depression
Adapted from Owens, et al.
The etiology of depression is complex and not yet fully understood but is thought to involve cognitive
(Watkins 2008; Gotlib & Joormann 2010), genetic (Mullins & Lewis 2017), and environmental (LeMoultet
2020) factors, as well as physiological factors such as hormones (Owenset al. 2014), inflammatory markers
(Lamerset 2019), and arousal and wakefulness regulation (Hegerl & Hensch 2014; Jawinskiet 2019).
Lifestyle factors are also thought to play a role, including most notably sleep, exercise, and diet (Lopresti,
Hood & Drummond 2013). The relationship between diet, nutrition, and mood is complex and likely to
involve interactions and reciprocal relationships. For example, it is suggested that stress and depression
can shape gut microbiota, which in turn may affect stress and depression (Madison & Kiecolt-Glaser 2019).
More on the gut-brain axis and role of gut microbiota in the “Gut Brain Axis” section, below. It is also
increasingly recognized that modern lifestyles may lead to unhealthy diets, which may in turn contribute
to both an obesogenic (Garcıa, Long & Rosado 2009; Bl€uher 2019) and “depressogenic” social
environment (Hidaka 2012). The obesity global pandemic (Abarca-Gomezet al. 2017) could be linked to
depression as the two factors often co-occur (Sutariaet al. 2019). In fact, researchers have noted that
obesity and depression may have a bi-directional relationship where increase in one is associated with
increase in the other over time (Luppinoet al. 2010; Marmorstein, Iacono & Legrand 2014). Furthermore,
obesity and depression might share common biological mechanisms (Milaneschiet al. 2019), including, for
example, inflammatory processes (Bellmore 2018).
One emerging approach to either the prevention or treatment of depression aims to improve diet and
nutritional status. Under this framework, it is acknowledged that diet and nutritional status have an
important yet complex relationship with mental health (Sanchez-Villegas & Martınez-Gonzalez 2013;
Sarriset al. 2015; Jacka 2017; Lassaleet al. 2019). Theoretically, nutrients from diet or supplements can
treat or prevent depression in two main ways: helping the brain to function well and providing
neuroprotective effects. It has been shown, for example, that omega-3 fatty acids have pluripotent
beneficial effects in the brain by upregulating adult neurogenesis (Beltzet al. 2007) and brain-derived
neurotrophic factor (BDNF) protein expression (Wu, Ying& Gomez-Pinilla 2004; Raoet al. 2007), promoting
metabolism, release, uptake, and receptor functions of key neurotransmitter systems (e.g. serotonin and
dopamine) (Grossoet al. 2014a) and regulating stress via the Hypothalamic-Pituitary-Adrenal Axis
(Thesinget al. 2018). Neuroprotection from nutrients may come in the form of anti-inflammatory
processes (Wallet al. 2010), reducing apoptosis (Harmset al. 2011) and reducing oxidative stress (Limaet
al. 2018). Research has assessed the links between specific nutrients and the prevention or treatment of
depression. For example, dietary omega-3 is associated with a reduced risk of depression (Grossoet al.
2016), omega-3 supplementation versus placebo has demonstrated a beneficial effect on depressive
symptoms (Liaoet al.2019), and vitamin D supplementation may benefit those with clinical depression (for
a review on the connection between vitamin D and depression, see Parker, Brotchie & Graham 2017).
However, it has also been argued that single nutrient supplementation is unlikely to be maximally
effective, given that nutrients are not consumed in isolation (Opieet al. 2015).
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Whole-Diet Approaches (Adapted from Owens, et al.)
A whole-diet approach is one that consists of eating predominantly or exclusively unprocessed or
unrefined foods including grains, nuts, seeds, fruit, and vegetables. Research in this area focuses on highquality diets that are nutrient dense and low in ultra-processed foods (e.g., the Mediterranean diet or
traditional diet). There is robust observational evidence to suggest that such high-quality diets are at least
associated with lower risk of depression (Molendijket al. 2018; Lassaleet al. 2019; Nicolaou, Colpo &
Vermeulen 2019) and in addition, there is likely to be a complex bidirectional relationship between the
two (Elstgeestet al. 2019). However, more work in this nascent field is needed to test the causal status of
nutrients and diet quality and the prevention of depression; more randomized controlled nutritional
intervention trials (RCTs) are required. Nevertheless, nutrition-based approaches are attractive
candidates for mental health prevention strategies for several reasons, including the fact that they have
the potential to reach many people and have additional wide-ranging positive health benefits: including
promoting healthy immune function (Wintergerst, Maggini & Hornig 2007), and reducing negative effects
of diabetes (Salas-Salvadoet al. 2015), heart disease (Grossoet al. 2017) and cancer (Auneet al. 2011). In
addition, healthy diets can encourage healthy weight loss which may itself provide wide-ranging health
benefits, potentially including preventing depression. Several studies have shown positive effects of
behavioral weight control on both depressed mood and weight (e.g., Brinkworthet al.2009;
Faulconbridgeet al. 2018) and as a result, nutritional interventions could also lead to health economic
benefits (Gyleset al. 2012). The recently completed MooDFOOD intervention (Rocaet al. 2016; Botet al.
2019) is one such randomized controlled prevention trial that investigated the role of nutrition and
nutrition-related psychological factors on depression. A recent meta-analysis of 16 randomized controlled
trials (RCTs; the majority looking at non-clinical depression) suggests that a whole-diet approach may
provide a small but significant benefit to reduce symptoms of depression. Examples include:
•

•

•

A trial that was excluded from the review cited above is the SMILES trial (Jacka et al. 2017) which
involved subjects diagnosed with clinical depression and reports significant differences in the
reduction of depression symptoms for a dietary support group versus a social support group.
HELFIMED trial (Parletta et al. 2019) was a whole-diet RCT for clinical depression that recruited
patients through a general practitioner (GP). GP-reported or self-reported depression included
subjects randomized to either a “MedDiet” group receiving nutrition education from dietitians
and nutritionists who received baskets of Mediterranean-style foods and attended cooking
workshops, and took fish oil supplements for 6 months, or a group who attended a social group
every two weeks for 3 months. The results showed a statistically significant reduction in
symptoms of depression for the MedDiet group, where 60% fewer participants experienced
‘extremely severe’ depression.
An additional clinical trial with results forthcoming is the PREDI-DEP trial. This trial will investigate
the effect of a dietitian-led Mediterranean-style diet supplemented with olive oil on the
prevention or the recurrence of depressive disorder among participants with a history of clinical
depression (Sanchez-Villegas et al. 2019).

Although there are still very few RCTs assessing integrative nutritional and psychological approaches to
depression prevention, the current literature includes evidence, albeit limited, that nutritional
supplements are not effective for the prevention of depression. It therefore remains an open question as
to whether future nutrition-based interventions will have the ability to prevent depression. There is some
evidence, on the other hand, for small beneficial effects of omega-3 supplements in the treatment of
5

depression as an adjunctive therapy. Whole-diet approaches may yield beneficial effects on depressive
symptoms in clinical depression (see the SMILES trial; Jacka et al. 2017), although most studies have used
non-clinical populations (Firth et al. 2019b). This latter fact leaves open the possibility that there is
potential for depression prevention effects through whole diet approaches, but more research is needed
in this area to ascertain this. Any recommendations for patients at risk or in treatment for depression
should be carefully taken. Always proceed with caution to ensure that we do not cause harm, either
directly through any iatrogenic effects (e.g., negative effects of supplements) or by inadvertently
signposting those in need, whether they are patients with clinical depression or individuals with elevated
symptoms or with known risk factors for disorder, to ineffective interventions, when they might otherwise
seek help from interventions known to be efficacious.
Adapted from Ljungberg et al.
Conversely, research in this area has also examined the effect of a pro-inflammatory dietary pattern on
risk for depression and indices for risk. A review published in the International Journal of Environmental
Research and Public Health analyzed 22 research studies containing over 455,000 participant reports. All
students included in their report had considered potential confounding factors, such as age, gender,
marital status, education, income, occupation, physical activity, smoking, alcohol, and body mass index.
From their report:
Several studies showed an association between dietary intake with inflammatory
potential and risk of depression in different populations [17,18,20,22,33]. Products
associated with less impact on systemic inflammation have been found to be vegetables,
whole grains, olive oil, and fish. Products such as sweets; refined flour; high-fat products;
red and processed meat were associated with a greater impact on systemic
inflammation [17]. The results showed that a pro-inflammatory diet was associated with
a significantly increased risk of depression in the subgroup of women; middle-aged
adults; and people with overweight and obesity. Thus, the relationship was strongest in
people with overweight and obesity [17]. An increased risk of depression was associated
with a high proportion of processed foods in the diet, and for each 10% increase of the
proportion of processed foods [18]. High intake of pro-inflammatory food was associated
with significantly increased risk of depressive symptoms [17,18,20,22]. In subgroups of
men, smokers and physically inactive, a diet consisting of a higher proportion of proinflammatory foods, significantly increased the risk of depressive symptoms [20].
Associations between food with inflammatory effect and increased risk of depression
were calculated with significance in a cross-sectional study performed in USA [22]. A
high intake of inflammatory diet was significantly associated with the occurrence of
frequent anxiety in the same study. In another study from USA, the results indicated a
significant association between inflammatory diet and risk of depression in women [33].
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Epilepsy and Ketogenic Diet
Adapted from D'Andrea et al.
Epilepsy is a disabling and common neurological disease, which can be controlled successfully in most
patients with one or more antiepileptic drugs. Approximately 30% of patients with epilepsy have
refractory epilepsy, that is, have a failure of adequate trials of two tolerated, appropriately chosen and
used antiepileptic drug schedules to achieve sustained relief of seizures (Picot et al., 2008; Kwan et al.,
2009). Some of these patients are not surgery candidates, so it is necessary to search for alternative
treatments for epilepsy, such as palliative surgery, neuromodulation, and a ketogenic diet (KD).
The classic ketogenic diet (CKD) is rich in lipids (90% calories from dietary fats) and protein, to produce
ketosis, and simulates a state of starvation. It is a rigid diet, mathematically and individually calculated,
and medically monitored. It must provide adequate vitamins and minerals. The CKD induces an effect like
a fasting state physiologically, in doing so altering the metabolism to use fats as a primary fuel source;
catabolism of fatty acids in the liver produces ketone bodies (KB) and the induction of urinary ketosis (Rho,
2017).
Recent studies have found a significantly positive outcome with the use of the KD for treatment of
refractory epilepsy in children and adults (Barborka, 1928; Neal et al., 2008; Kverneland et al., 2015; Liu
et al., 2018).

History of the classic ketogenic diet and therapeutic potential for epilepsy:
Two Parisian physicians, G. Guelpa and A. Marie, recorded the first modern use of starvation as a
treatment for epilepsy in 1911 (Wheless, 2008). More modern use of this therapy began in the early
1920s (Lima et al., 2014; Yuen and Sander, 2014), when Drs. Stanley Cobb and W.G. Lennox at
Harvard Medical School observed the effects of starvation as a treatment for epilepsy, noting that
seizure improvement typically occurred after 2–3 days (Wheless, 2008). In the same period, Dr.
Russel M. Wilder a physician at the Mayo Clinic in Minnesota, suggested that a specific diet could
produce similar benefits to fasting, and proposed a diet that produced ketonemia. He studied a
series of patients with epilepsy and demonstrated a result equivalent to fasting and that was
maintained for a much longer period. This new concept of diet was designated the “KD”.
Adapted from Lambert et al.
Despite the efficacy of the ketogenic diet, most patients discontinue the diet. Reasons for decreasing diet
adherence or discontinuing are due to the diet’s unpalatable and restrictive features. As a result, new
variations of the classic ketogenic diet have emerged, and there are now five variations (also described in
a video linked in Module 5):
1.
2.
3.
4.
5.

the classical KD [1],
medium chain triglyceride KD (MCT KD) [2],
modified Atkins diet (MAD) [3],
low glycemic index treatment (LGIT) [4]
modified ketogenic diet (MKD) [5]

Several studies have shown that the new variants of the KD have some degree of efficacy to the CKD
(Kossoff et al., 2006; Tonekaboni et al., 2010; Coppola et al., 2011; Miranda et al., 2012; El-Rashidy et al.,
7

2013). This indicates that variations of the KD can (at times) keep a patient in a state of ketosis. Knocking
a previously ketogenic patient out of ketosis can cause epileptic seizures to return. Table 5.1 describes
variations of the KD and their effect on seizure protection.
Modified Atkins Diet (MAD)

-

Low Glycemic Index (LGIT)

Table 5.1 Variations of the KD

-

1:1 ratio of fat to carbohydrates to protein
Dietary fat is encouraged, and carbohydrates are limited to 10-20
g/day in children and 15-20 g/day in adults
Generally effective in children, lower carbohydrates very important
in the first 3 months
Generally effective in adolescents and adults (higher adherence);
proportion of patients showing >50% seizure control ranges from
20 to 70%
60% fats; 30% protein; 10% carbohydrates
Low glycemic index (GI) foods (GI < 50)
GI measures the tendency of a food to raise the blood glucose
levels, compared to an equivalent amount of reference
carbohydrate, usually glucose
Low # of high-quality studies
Proven effective in treatment of focal and generalized epilepsies

As presently understood, the ketogenic diet is involved in multiple mechanisms responsible for
biochemical alterations, including cellular substrates and mediators responsible for neuronal
hyperexcitability. However, it is not yet known with certainty whether the success of the KD for refractory
epilepsy is due to a single or several mechanisms (Bough and Rho, 2007; Lutas and Yellen, 2013; Rho,
2017; Youngson et al., 2017); in other words, no one can say with 100-percent certainty why it works – it
just does! This is discussed further below.
KDs are the treatment of choice for certain neurometabolic disorders, such as glucose transporter type 1
deficiency syndrome and pyruvate dehydrogenase complex deficiency, and are an effective treatment
option for drug-resistant epilepsy (DRE) [6,7]. KDs are a resource-intensive treatment, with a dietitian as
an essential member of the multidisciplinary team (MDT) [6,8]. Regimens are demanding of the skill and
expertise of the dietitian due to their inherent complexity, the need for individualized dietary calculation
(to take into consideration clinical condition, age, feeding ability, nutritional requirements, educational
status, and socio-economic circumstances), meal planning and recipe development, regular
patient/caregiver contact, and liaison with other healthcare professionals. On-going follow-up is crucial
to fine-tune the diet, manage any adverse side effects, and for its safe and successful discontinuation.
Although attrition from KDs occurs (due to poor diet tolerance or lack of efficacy) [7], and this will impact
diet duration, recommendations are that KDs for DRE are discontinued if unsuccessful after a minimum
of three months and after two years in patients where they have been efficacious [6]. However, there is
no maximum duration for the use of KDs in DRE, and 30% of cases continue for longer or return to diet if
seizures reoccur after weaning off [6,9].
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Plausible Mechanisms for Efficacy of Ketogenic Diet to Effect Seizure Activity
•

•

•

•

•

Energy and Neuronal Metabolism: In normal conditions, the energy substrate for neurons is
glucose. To facilitate its diffusion through the blood-brain barrier, glucose transports are present
in the brain capillary endothelial layer (Greene et al., 2003). The metabolism of glucose produces
rapidly available energy that is necessary and utilized for seizure activity. However, in patients on
the KD, the blood glucose energy levels are low, and the brain begins to use ketone bodies
(acetoacetate, hydroxybutyrate) for energy. This anaerobic metabolism slows the energy
availability, which reduces seizures. The anticonvulsant propriety of a decrease in glucose
metabolism has been shown in experimental models in which the administration of 2-Deoxy-Dglucose elevates the seizure threshold (Garriga-Canut et al., 2006). The anticonvulsant effect of
the KD can be quickly reversed after glucose infusion (Huttenlocher, 1976). Thus, the presence of
ketone bodies and the reduction of glucose levels are both potential mechanisms underlying the
anti-convulsive properties of the KD.
Synaptic Function: Chronic ketosis elevates the brain energy reserve via stabilization and
reduction of excitability of synapses (Devivo et al., 1978). The energy reserve is directly associated
with mitochondria, which are important elements to consider in the antiepileptic effect of KD.
Bough et al. (2006) demonstrated an increase in mitochondria biogenesis in an experimental
model of rats fed with KD (Bough et al., 2006). The increase in mitochondrial metabolism leads to
an increase in ATP production, which activates KATP, in turn attenuating neuronal excitability.
Neurotransmitter Function: The KD interferes with the concentration of gamma aminobutyric
acid, or GABA. There is evidence of increased GABA levels in the cerebrospinal fluid of patients
that follow a ketogenic diet. GABA is a major inhibitory neurotransmitter.
Microbiome: Several metabolic pathways are known to be modulated by the gut microbiota.
Olson et al. (2018) demonstrated the impact of gut microbiota on the anti-seizure effect of KD.
She found that KD modifies the gut microbiota, with a decrease in alpha-diversity and increases
in the putatively beneficial bacteria Akkermansia muciniphila and Parabacteroides sp. This
microbiota transformation leads to changes in the colonic luminal metabolome, with a decrease
in gamma-glutamyl amino acids. This increases the GABA/glutamate content in the brain by
decreasing gamma-glutamyl amino acids in the blood (Olson et al., 2018). In an acute electroshock
model, it is reported that KD confers protection against seizures. Moreover, KD decreases the
frequency of spontaneous seizures in Kcna1 knockout mice (Kim et al., 2015. Overall, changes in
the gut microbiota associated with adherence to a KD seem to be important for seizure
protection.
Inflammation: The role of inflammatory cytokines in epilepsy is well known, and there is evidence
that KD also interferes with pro-inflammatory cytokines. Dupuis et al. (2015) showed a peripheral
and brain reduction of interleukin 1β and other pro-inflammatory cytokines in rats treated with
KD in the LPS model.
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Dementia and Alzheimer’s Disease
Adapted from de Crom et al.
Diet has gained increasing interest as a target for developing preventive opportunities against dementia,
as it impacts several mechanisms underlying dementia, including oxidative stress, inflammation, and
vascular abnormalities. Accordingly, numerous studies have linked adherence to healthy dietary patterns
to a slower rate of cognitive decline [1] and a decreased risk of dementia [2]. Although such healthy dietary
patterns may be sub-optimal for brain health. Therefore, the Mediterranean-Dietary Approaches to Stop
Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) diet has been developed [3], to
uniquely emphasize foods linked to brain health, such as green leafy vegetables [4, 5] and berries [6].
Adherence to the MIND diet has indeed been linked to better cognitive performance [7, 8], less cognitive
decline [3, 9,10,11], and a lower dementia risk [12, 13]. A general description of guidelines,
recommendations and restrictions are outlined in Table 5.2.
Mediterranean-DASH = MIND Diet Guidelines and Restrictions
At least three servings of whole grains a day
Green leafy vegetables (such as salad) at least six times a week
Other vegetables at least once a day
Berries at least twice a week
Red meat less than four times a week
Fish at least once a week
Poultry at least twice a week
Beans more than three times a week
Nuts at least five times a week
Use predominantly olive oil for cooking
Fried or fast food less than once a week
Less than a tablespoon of butter or margarine a day
Less than a serving of cheese a week
Less than five pastries or sweets a week
One glass of wine or other alcoholic drink a day

+
+
+
+
+
+
+
+
+
+
-

Table 5.2 Principles of the MIND Diet. The MIND diet includes 10 food groups to incorporate with frequency and 5
groups to limit. The plus (+) sign indicates inclusion and the minus (-) sign exclusion as indicated.

While both the MIND and Mediterranean diets yield similar reductions in Alzheimer's risk, the MIND diet
is more flexible, which may make it easier to follow for some Americans. For example, the Mediterranean
diet recommends eating fish multiple days a week, which can be a challenge.
Another interesting takeaway from the research describing MIND’s effectiveness is that you don't have to
have a perfect diet to benefit. While adults who followed the diet most closely (an average score of 9.6
points out of 15) saw the biggest drop in their Alzheimer's risk, the ones who scored in the middle (7.5
points) still cut their risk by over a third. Consider targeting just one or two of the habits above to improve
your score — and your brain health.
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Dysphagia and Diet
Adapted from the NIH’s Informational Page on Dysphagia
Patients with various neurological or other disorders may suffer with dysphagia. This section includes a
brief definition, description, and strategies for mitigation.
Defined. Patients with dysphagia have difficulty swallowing and may even experience pain while
swallowing (odynophagia). Some people may be completely unable to swallow or may have trouble safely
swallowing liquids, foods, or saliva. When that happens, eating becomes a challenge. Often, dysphagia
makes it difficult to take in enough calories and fluids to nourish the body and can lead to additional
serious medical problems.
Causes of dysphagia. Dysphagia occurs when there is a problem with the neural control or the structures
involved in any part of the swallowing process. Weak tongue or cheek muscles may make it hard to move
food around in the mouth for chewing. A stroke, Alzheimer’s disease, or other disorder may make it
difficult to start the swallowing response, a stimulus that allows food and liquids to move safely through
the throat. Another difficulty can occur when weak throat muscles, such as after cancer surgery, cannot
move all the food toward the stomach. Dysphagia may also result from disorders of the esophagus.
Dysphagia has many possible causes and happens most frequently in older adults. Any condition that
weakens or damages the muscles and nerves used for swallowing may cause dysphagia. For example,
people with diseases of the nervous system, such as cerebral palsy or Parkinson’s disease, often have
problems swallowing. Additionally, stroke or head injury may weaken or affect the coordination of the
swallowing muscles or limit sensation in the mouth and throat.
People born with abnormalities of the swallowing mechanism may not be able to swallow normally.
Infants who are born with an opening in the roof of the mouth (cleft palate) are unable to suck properly,
which complicates nursing and drinking from a regular baby bottle. Finally, for people with dementia,
memory loss and cognitive decline may make it difficult to chew and swallow.
Swallowing is a complex process. Some 50 pairs of muscles and many nerves work to receive food into
the mouth, prepare it, and move it from the mouth to the stomach. This happens in three stages. During
the first stage, called the oral phase, the tongue collects the food or liquid, making it ready for swallowing.
The tongue and jaw move solid food around in the mouth so it can be chewed. Chewing makes solid food
the right size and texture to swallow by mixing the food with saliva. Saliva softens and moistens the food
to make swallowing easier. Normally, the only solid we swallow without chewing is in the form of a pill or
caplet. Everything else that we swallow is in the form of a liquid, a puree, or a chewed solid.
The second stage begins when the tongue pushes the food or liquid to the back of the mouth. This triggers
a swallowing response that passes the food through the pharynx, or throat (see figure). During this phase,
called the pharyngeal phase, the larynx (voice box) closes tightly and breathing stops to prevent food or
liquid from entering the airway and lungs.
The third stage begins when food or liquid enters the esophagus, the tube that carries food and liquid to
the stomach. The passage through the esophagus, called the esophageal phase, usually occurs in about
three seconds, depending on the texture or consistency of the food, but can take slightly longer in some
cases, such as when swallowing a pill.
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Treatments for Dysphagia. There are different treatments for various types of dysphagia. Medical doctors
and speech-language pathologists who evaluate and treat swallowing disorders use a variety of tests that
allow them to look at the stages of the swallowing process. One test, the Flexible Endoscopic Evaluation
of Swallowing with Sensory Testing (FEESST), uses a lighted fiberoptic tube, or endoscope, to view the
mouth and throat while examining how the swallowing mechanism responds to such stimuli as a puff of
air, food, or liquids.
A videofluoroscopic swallow study (VFSS) is a test in which a clinician takes a videotaped X-ray of the
entire swallowing process by having patients consume several foods or liquids along with the mineral
barium to improve visibility of the digestive tract. Such images help identify where in the swallowing
process patients are experiencing problems. Speech-language pathologists use this method to explore
what changes can be made to offer a safe strategy when swallowing. The changes may be in food texture,
size, head and neck posture, or behavioral maneuvers, such as “chin tuck,” a strategy in which patients
tuck their chin so that food and other substances do not enter the trachea when swallowing. If the patient
is unable to swallow safely despite rehabilitation strategies, then medical or surgical intervention may be
necessary for the short-term as they recover. In progressive conditions such as amyotrophic lateral
sclerosis (ALS, or Lou Gehrig’s disease), a feeding tube in the stomach may be necessary for the long-term.
For some people, treatment may involve muscle exercises to strengthen weak facial muscles or to improve
coordination. For others, treatment may involve learning to eat in a special way. For example, some
people may have to eat with their head turned to one side or looking straight ahead. Preparing food in a
certain way or avoiding certain foods may help in some situations. For instance, people who cannot
swallow thin liquids may need to add special thickeners to their drinks. Other people may have to avoid
hot or cold foods or drinks.
For some, however, consuming enough foods and liquids by mouth may no longer be possible. These
individuals must use other methods to nourish their bodies. Usually this involves a feeding system, such
as a feeding tube, that bypasses or supplements the part of the swallowing mechanism that is not working
normally.
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Gut-Brain Axis
Adapted from Carabotti et al. and Verduci et al.
Insights into gut-brain crosstalk have revealed a complex communication system that not only ensures
the proper maintenance of gastrointestinal homeostasis, but is likely to have multiple effects on affect,
motivation, and higher cognitive functions. The complexity of these interactions is enclosed in the
denomination of “gut-brain axis” (GBA) [1]. Its role is to monitor and integrate gut functions as well as to
link emotional and cognitive centers of the brain with peripheral intestinal functions and mechanisms
such as immune activation, intestinal permeability, enteric reflex, and entero-endocrine signaling. The
mechanisms underlying GBA communications involve neuro-immuno-endocrine mediators.
This bidirectional communication network includes the central nervous system (CNS), both brain and
spinal cord, the autonomic nervous system (ANS), the enteric nervous system (ENS), and the hypothalamic
pituitary adrenal (HPA) axis. The autonomic system, with the sympathetic and parasympathetic limbs,
drives both afferent signals, arising from the lumen and transmitted though enteric, spinal, and vagal
pathways to CNS, and efferent signals from CNS to the intestinal wall. The HPA axis is considered the core
stress efferent axis that coordinates the adaptive responses of the organism to stressors of any kind [2].
It is a part of the limbic system, a crucial zone of the brain involved in memory and emotional responses.
Environmental stress, as well as elevated systemic pro-inflammatory cytokines, activate this system that,
through secretion of the corticotropin-releasing factor (CRF) from the hypothalamus, stimulates
adrenocorticotropic hormone (ACTH) secretion from pituitary gland that, in turn, leads to cortisol release
from the adrenal glands. Cortisol is a major stress hormone that affects many human organs, including
the brain.
Both neural and hormonal lines of communication combine to allow brain to influence the activities of
intestinal functional effector cells, such as immune cells, epithelial cells, enteric neurons, smooth muscle
cells, interstitial cells of Cajal, and enterochromaffin cells. These same cells, on the other hand, are under
the influence of the gut microbiota [3], whose contributing role in brain-gut reciprocal communications
has recently been uncovered and continues to be investigated. Figure 5.1 illustrates the bidirectional
communication between the brain and gut via hormonal and neural pathways, where a tipping or leverage
point in this diagram is diet. A diet rich in fiber serves a fuel source to resident microbes of the colon,
promoting production of short chain fatty acids (SCFAs) and branched-chain fatty acids (BCFAs). Further,
gut microbes themselves are known producers of some neurotransmitters which can act locally. The
concept of a microbiome-mediated gut-brain axis is emerging and being investigated.
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Figure 5.1 The microbiome-mediated gut-brain axis.
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Introduction, Precision Nutrition, and Cancer Therapy
Adapted from Lelièvre SA et al.

Cancer is a global burden. The most common types of cancer in the United States are illustrated
in Figure 6.1, with new breast and prostate cancer diagnoses expected to overshadow the other
types in frequency. Lung cancer is the leading cancer killer in both men and women in the United
States.
According to W.H.O., 30% of cancers might be linked to dietary factors in industrialized countries.
Cancers of the colon, rectum, prostate, oral cavity, larynx, pharynx, esophagus, stomach, liver,
pancreas, uterus, endometrium, kidney and breast are those listed by W.H.O. as influenced by
nutrition.11; 9

Figure 6.1 The Most Common Types of Cancer in the U.S.
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Adapted from Reglero et al.

Over the years, numerous epidemiological studies have been carried out to link the diet with
cancer, either from a preventive approach or by associating the consumption of certain food
products with tumor generation and growth. Many of these reports are summarized in this
chapter, in tables specific to the most prevalent types of cancer in the United States. Generally,
a whole-foods diet approach that emulates principles of the Mediterranean diet have emerged
as significant factors to reduce risk for developing common cancers.
However, in parallel to the development of precision therapies in medicine, precision nutrition is
an emerging science that relies on well-established factors such as genetic and epigenetic
variation [30] and the microbiome [31]. It has recently been shown that the treatment of human
cell lines with different bioactive foodstuffs influences their physiological attributes depending
on their ability to influence the expression of different genes [32]. The possibility of using
nutritional therapies against cancer, as a complementary medicine, is internationally accepted
due to its advantages of less toxicity and better acceptance by patients [33]. In the case of breast
cancer, complementary phytochemical therapy in adjuvant treatments has been proposed both
with preventive effects and during conventional treatments after diagnosis [34], concluding that
nutritional strategies can be effective for prevention of relapse [35].
Epidemiological studies triggered further research in terms of molecular mechanisms, which have
significantly improved the effectiveness of phytotherapy, entering the context of precision
nutrition [36]. Recent studies on the association between prevention, treatment, and recurrence
of cancer suggest the benefit of investigating the link between specific food components and
certain health outcomes [37]. Since very specific therapeutic targets must be reached, precision
nutrition must be based on individual foodstuffs with well-established mechanisms of action at
the molecular level in terms of gene expression modulation and signaling pathways involved in
proliferation, invasion, angiogenesis, and metastasis or apoptosis [38]. For example, it has been
shown that it is possible to attack genetic instability associated with cancer through nutritional
strategies that inhibit proliferative signaling, attenuate oncogenic metabolism, and block
inflammation [39].
The biological activity of food polyphenols, a broad family of compounds with representatives in
virtually all foods, has been specially studied for decades, since they have in common an intense
antioxidant activity that suggests other potential health outcomes, for example in breast cancer
[40]. Recently, intensive research has been carried out to determine the preventive or
therapeutic activity of different natural phenolic compounds [41], opening ways for its
application in new treatments of various types of cancers such as breast [42,43,44,45], colon [46],
or prostate [47,48]. Some synthetic phenolic compounds have also been successfully studied for
the treatment of some cancers [49]. In addition to polyphenols, curcumin (diferuloylmethane) is
one of the most studied foodstuffs in recent years as a potential therapeutic product for cancer
and more specifically for leukemia [50]. Traditional food products, such as rosemary extract, have
been proposed as potential ingredients of precision nutritional supplements in cancer therapy,
4

identifying molecular mechanisms related to the effects and the interactions with currently used
anticancer agents [51]. In the case of colorectal cancer, lipid-metabolism-related genes have
acquired relevant interest for precision nutrition therapies, since a wide range of tumorigenic
steps can be influenced by lipid metabolism, both in primary tumors and distal metastasis [52].
Certain therapeutic strategies based in diet patterns during adjuvant treatments are also
sometimes considered as precision therapies [53]. Finally, multi-targeting profiles of food
ingredients are being investigated regarding their potential roles triggering anti-cancer molecular
mechanisms through the modulation of certain gene expressions or signaling pathways [54].
Lung, breast, prostate, and colon cancers have the highest overall incidence and represent 36.4%
of the total diagnosis according to GLOBOCAN 2018, a report that gathers data from the
International Agency for Research on Cancer of the World Health Organization [1]. Besides their
high occurrence, these types of cancer add up to a mortality rate that reaches 49.2% of the
diagnosed cases. In addition, blood malignancies occur with a rate of 6.5%, an incidence
particularly worrying as it is the highest in children and young adults.
In the last five years, international scientific production related to new basic and translational
discoveries on cancer has grown by 5% annually. Lung, colon, breast, prostate, and leukemia
cancers account for 51% of scientific publications on cancer in this period (Web of Science,
Clarivate Analytics, Philadelphia, PA, USA). Recently, an increasing number of investigations
based on genomics and epigenomics are focusing on the improvement of tumor classification,
the relationship between cancer and microbiota, or the discovery of new therapeutic targets in
metabolism, to develop specific therapies in the context of precision medicine.
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Nutritional Considerations in Cancer Prevention, Treatment, and
Recovery
COLORECTAL CANCER
From Veettil SK et al.
Colorectal cancer (CRC) is the third most diagnosed cancer among men and the second most
common cancer among women worldwide.1 The etiology of CRC is multifactorial, with both
genetic and environmental factors playing a role.2 Evidence suggests that modifiable lifestyle
factors, including excess adiposity, poor diet, and physical inactivity, play an important role in the
occurrence and progression of this disease.2,3
Several systematic reviews with meta-analysis of prospective observational studies have
summarized evidence for the associations between dietary factors (e.g., foods and food groups,
beverages, alcohol, macronutrients, and micronutrients) and the incidence of CRC. Interestingly,
animal protein (particularly red meat) has emerged as a dietary factor which can increase one’s
risk for developing colorectal cancer. A summary of epidemiological studies examining the
association of red meat intake with CRC risk are summarized in Table 6.1. To reduce risk of
developing CRC, patients should incorporate plenty of dietary fiber, foods rich in Calcium (such
as dairy products and yogurt), whole grains, vegetables, and fruits.
Author, Year, Country
Willett WC, 1990, USA

Study Design
Observational

Norat A, 2005, 10 European
Countries

Case-Control

Chao A, 2005, USA

Observational

Cross AJ, 2010, USA

Observational

Chan DS, 2011, N/A

Meta-analysis
of 10 cohort
studies

Result
Positive Association:
risk ratio (RR) of CRC in women who ate
beef, pork or lamb every day was 2.49, as
compared with those reporting <1 serving
per month
Positive Association:
high intake (>160 g/day) group had a risk
1.4-fold as compared with the lowest
intake (<20 g/day)
Positive Association:
long term consumption increased the risk
of CRC in the distal large intestine
Positive association:
Heme iron, nitrite, heterocyclic amines
from meat may explain associations
Positive Association:
17% increased risk per 100g per day of red
meat and an 18% increase per 50g per day
of processed meat

Table 6.1 Summary of epidemiological studies examining the association of red meat intake with colorectal cancer
(CRC) Adapted from Thanikachalam K et al.
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BREAST CANCER
Adapted from Buja et al.
Breast cancer (BC) is the most frequently diagnosed female cancer, accounting for 29% of cancers
in women [1]. It is important for primary prevention to include reducing modifiable risk factors,
such as obesity, a sedentary lifestyle, and a poor diet. Each of these factors can have various
effects, depending on breast tissue type and age (premenopausal and menopausal).
As concerns diet, the role of alcohol as a risk factor has been well established: the results of the
2011 EPIC (European Prospective Investigation into Cancer and Nutrition) survey found that 5%
of BCs could be attributable to alcohol consumption [2].
Numerous studies have addressed the role of several other foods too, sometimes reporting
divergent results. For example, according to the EPIC survey, a diet rich in saturated fat is
associated with a higher risk of estrogen- and progesterone-positive cancer, with a significantly
higher hazard ratio [3]. Similar results emerged from a Swedish cohort survey, in which a high
dietary fat consumption seemed to lead to a significant increase in the risk of developing BC [4].
On the other hand, a case-control survey conducted in China in 2008 found no significant
association between the various types of dietary fat and the odds of cancer [5]. Red meat and
animal proteins seem to be associated with an increase in the risk of neoplastic disease,
suggesting that consuming them in large amounts anticipates menarche, and this is recognized
as a risk factor and predictor of BC [6]. Several epidemiological studies have shown that
consuming soy products is associated with a lower incidence of hormone-related tumors,
including BC, due to the properties of isoflavones and phytoestrogens
Author, Year
Gandini, 2000

Dong, 2011

Study Design
Random effects model;
fixed effects model
Random effects model &
fixed effects model
Random effects model

Dong, 2011

Random effects model

Trock, 2006

Result
High Veg consumption, High VitC and βcarotene intake w/ protective effect against BC
High soy intake was modestly associated with a
lower BC risk
Total dairy food consumption significant
inversely associated with BC risk
Dietary soy isoflavone intake was associated w/
a significantly reduced risk of BC in Asian
populations

Table 6.2 Summary of epidemiological studies examining the association of dietary trends and food compounds
with breast cancer (BC); adapted from Buja et al.
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PROSTATE CANCER
Matsushita M, Fujita K, Nonomura N. Influence of Diet and Nutrition on Prostate Cancer. Int J
Mol Sci. 2020;21(4):1447. Published 2020 Feb 20. doi:10.3390/ijms21041447
Prostate cancer (PCa) is the second most common type of cancer and the fifth most common
cause of cancer-related death in men worldwide [1]. In 2018, ~1.2 million new cases of PCa were
diagnosed, and nearly 360,000 men died of PCa worldwide [1]. The incidence of PCa typically
varies widely in residential areas and is ~6-fold higher in Western countries than in non-Western
countries [2].
One reason for the variability in PCa incidence in residential areas concerns innate factors, such
as racial differences. African Americans have the highest rate of PCa, followed by Caucasians,
whereas Asians have the lowest. In general, there is a 3-fold difference between Asians and
African Americans [3]. These results are likely related to differences in genetic variation and
polymorphism among races; however, Japanese men who have emigrated to Western countries
have an increased incidence of PCa relative to Japanese residents in Japan [4,5]. This suggests
that both innate factors and environmental factors, such as lifestyle, can influence PCa
development.
Various environmental factors, such as diet, obesity, smoking, and exercise, are reportedly
associated with PCa. Tobacco smoking is a risk factor in many types of cancer, and similarly, in
PCa, smoking is associated with a significantly increased risk of overall mortality, cancer-specific
mortality, and recurrence [6,7]. Exercise therapy often results in physical and mental
improvements. According to an analysis of 752 Canadians, an active lifestyle reduced PCa risk
[odds ratio (OR) = 0.8, 95% confidence interval (CI) = 0.6–0.9] [8]; however, there was no clear
association between exercise and PCa in a recent meta-analysis of 28,707 cases [relative risk (RR)
= 1.00, 95% CI = 0.99–1.01] [9]. Other lifestyle factors such as sleep and nutrition are reported to
have effects. Table 6.3 summarizes specific nutrients and/or dietary patterns shown to reduce
PCa risk, along with the reported potential mechanisms of action. Table 6.4 summarizes specific
nutrients and/or dietary patterns show to increase PCa risk, along with potential mechanisms of
action.
The effects of diet and nutrients on PCa pathogenesis and progression have received increasing
attention. Animal studies have reported that certain nutrients, including fat, protein,
carbohydrates, vitamins (vitamin A, D and E), and polyphenols, are indeed involved in PCa
pathogenesis, and progression through several mechanisms, including inflammation, antioxidant
effects, and the effects of sex hormones. However, contrasting findings of clinical studies have
deterred determining which nutrients have a positive or deleterious effect on PCa incidence
and/or progression. Weak effects of single nutrients and interactions among different nutrients
have resulted in controversial results among clinical studies conducted among residents with
different dietary backgrounds. Therefore, it is important to assess the effect of dietary patterns
that comprehensively summarize nutrient intake. It is generally believed that a healthy dietary
8

pattern (e.g., low in meat and high in vegetables) can help prevent PCa and lifestyle-related
diseases; however, no evidence is available regrading this belief.

Influence of Diet and Nutrition on PCa Risk Reduction
Nutrient or Dietary Pattern
Reported Mechanism(s)
Unsaturated fatty acids (fish or
Decrease in estradiol, testosterone, and androgen
vegetable-derived oils)
receptors
Vitamin A (Lycopene) from Tomatoes Decrease in androgen metabolism; antioxidant effect
Vitamin D (Calcitriol) from fish, dairy Promotion of immune cell differentiation
products, mushrooms
Catechins from green tea
IGF-I signaling pathway and COX-2 mediated antiinflammatory effects
Isoflavones from legumes
Estrogenic effects; antioxidant effects; inhibition of
tyrosine kinase; suppression of NFΚB
Prudent dietary pattern
N/A

Table 6.3 Summary of nutrients/ bioactive compounds and their reported mechanisms associated with reduced
prostate cancer (PCa) risk; adapted from Matsushita et al.

Influence of Diet and Nutrition on Increasing PCa Risk
Nutrient or Diet Pattern
Reported Mechanism(s)
Total fat from animal meats and
IL-6/STAT3 pathway, macrophage infiltration; increase
butter
in local androgens
Heterocyclic amines from wellMast cell production and macrophage infiltration
cooked meats
Dairy products such as milks and
N/A
cheese
Western dietary pattern
N/A

Table 6.4 Summary of nutrients/ bioactive compounds and their reported mechanisms associated with increased
prostate cancer (PCa) risk; adapted from Matsushita et al.
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Bioactive Food Compounds
Adapted from Reglero et al.

As indicated in the Introduction, recent advances in precision nutrition are related to bioactive
food compounds. There are a myriad of bioactive food compounds and components in plantbased foods; a partial list includes polyphenols, phytosterols, carotenoids, tocopherols and
tocotrienols. These extra-nutritional constituents typically occur in very small quantities in foods
yet are intensively studied to evaluate their effects on health that begin at the cellular level.
Cancer heterogeneity makes its treatment particularly challenging. Innovative therapies for
patients are continuously being tested, and progress has been made in the last years developing
early diagnosis protocols and improving patient prognosis. However, despite these efforts, a high
percentage of patients relapse after surgery or initial therapy. Cancer relapse involves a great
number of different molecular mechanisms that vary form one patient to another. This points to
precision medicine as a key element to personalize cancer treatment and prevent relapse and
suggest the value of new effective and safe compounds that potentiate the effects of alreadyknown chemotherapy agents. In this sense, the growing number of studies regarding the
mechanisms of several bioactive compounds from foods in the treatment of different types of
cancer open a new layer in precision cancer therapy. Its association with specific genetic targets
or different molecular pathways inhibiting tumor growth and metastasis constitutes an
important customization component. Some bioactive food compounds show high synergism with
several chemotherapy drugs, acting as enhancers of these anti-tumor effects or even sensitizing
and reverting chemotherapy resistance. In essence, bioactive food compounds and/or
components could emerge as novel complementary agents that can be useful in precision
nutrition therapies addressing relapse prevention.
Epigallocatechin-gallate (EGCG), a flavonoid present in green tea, has been shown to inhibit
tumor cell growth and increase apoptosis, promoting tumor suppression. This compound
sensitizes human colon cancer cells to 5-fluorouracil, increasing the effects of adjuvant treatment
and improving prognosis, and finally reducing tumor relapse risk [68]. EGCG can also prevent lung
cancer relapse in lung cancer mouse xenografts by blocking the cancer stem-cells-like growth
through the modulation of the hsa-mir-485-5p/RXRα axis and downregulating protein acetylation
in lung carcinoma cells [65,66]. EGCG has been also been predicted to affect several pathways
involved in cell death and survival, potentially leading to a reduced cancer progression [67].
However, further molecular validations are needed in this sense.
Quercetin is another flavonoid with interesting features for relapse prevention; it is present in
vegetables such as onions. Quercetin promotes apoptosis and inhibits cell proliferation by
modulating important signaling targets as PI3K/Akt or NF-κB effectively eliminating prostate
CSCs. It also limits cell migratory capacity and progression of prostate cancer cell lines by the
downregulation of MK [71]. In breast cancer, quercetin can help preventing relapse by decreasing
expression and activation levels of mTOR, PI3K and Akt proteins leading to a significant inhibition
of MCF7 cancer cell proliferation [72].
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Apigenin, present in fruits, vegetables, and food herbs such as parsley, is another flavonoid with
potentially interesting effects for the development of precision nutrition products. This
compound improves the effectiveness of adjuvant therapy with cisplatin enhancing both
cytotoxicity and its anti-migratory effect on prostate cancer stem cells [57]. Apigenin also helps
preventing metastasis and relapse in non-small cell lung cancer cell lines and in an in vivo
orthotopic bioluminescent xenograft model by inhibiting cell migration and invasion [58].
Naringenin is another interesting flavonoid, obtained from citrus peel, shown to inhibit
proliferation and to induce apoptosis in prostate cancer cells [69].
Procyanidin-B2-3,3″-di-O-gallate (B2G2) can be extracted from grape seeds and has been shown
to target both differentiated cells and CSCs leading to tumor mass reduction [70].
Curcumin is another bioactive food product that has been the subject of former numerous
studies. Its anti-cancer effects, due its ability to modulate critical anti-apoptotic effectors such as
Bcl-xl and NF-κB, are of prominent interest in potential relapse prevention treatments. Moreover,
curcumin synergizes with vesicular stomatitis virus (VSV)-based oncolytic treatments modulating
antiviral responses and components of the intrinsic apoptotic pathway in a prostate cancer cell
model [59]. Furthermore, in colorectal cancer, curcumin can modulate gene expression of HSPA5,
SEC61B, G6PD, HMOX1, and PDE3B, affecting essential pathways like DNA replication or the cell
cycle. On the other hand, the synergy of curcumin and oligomeric proanthocyanins emerges as
an opportunity to develop effective therapies, since both compounds share similar molecular
mechanisms [60]. Recently, relevant effects of curcumin in breast cancer cell models have been
discovered, being that this compound is able to increase the expression of E-cadherin and
decrease the expression of mesenchymal markers [61]. It has been also shown that curcumin
enhances the effect of some targeted drugs used in cancer such as gefitinib, an EGFR inhibitor,
inducing autophagy-mediated apoptosis. This observation opens opportunities for the use of this
compound with treatments to prevent cancer relapse [62].
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Figure 6.2 Bioactive food compounds and natural extracts with proven effects in cancer treatment. Reglero et al.
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CULINARY STRATEGIES & MODIFICATIONS
American Cancer Society
Certain types of cancer and its treatment(s) can change your senses of taste and smell. This
effect can last weeks to months. Common causes may include types of tumors in the head and
neck area, radiation to the head and/or neck area, certain kinds of chemotherapy and targeted
therapy, mouth sores and/or dryness due to certain treatments, and some medications used to
help with other side effects or other non-cancer problems can also affect taste and smell.
Changes in taste and smell can very often affect appetite. Patients may have a reduced or altered
sense of smell, or even have an enhanced sense of smell. Patients may have a bitter or metallic
taste in the mouth, food may taste too salty, too sweet, or have no taste at all.
There are several strategies that patients and caregivers can employ to attempt to alleviate any
or all side effects; these are summarized in Table 6.5
Strategies to Address Metallic Taste
Try using plastic forks, spoons, and knives and glass cups and plates.
Season foods with tart flavors. Use lemon wedges, lemonade, citrus fruits, vinegar,
and pickled foods. (If you have a sore mouth or throat, do not do this.)
Try sugar-free lemon drops, gum, or mints.
Keep your mouth clean and brush your teeth to help ease bad tastes.
Try fresh or frozen fruits and vegetables instead of canned.
Strategies to Address Altered Taste
Counter a salty taste with added sweeteners, a sweet taste with added lemon juice
and salt, and a bitter taste with added sweeteners.
Rinse your mouth with a baking soda, salt, and water mouthwash before eating to
help foods taste better. (Mix 1 teaspoon salt and 1 teaspoon baking soda in 4 cups of
water. Shake well before swishing and spitting.)
Serve foods cold or at room temperature. This can decrease the foods’ tastes and
smells, making them easier to tolerate.
If red meats taste strange, try other protein-rich foods like chicken, fish, beans or
peas, tofu, nuts, seeds, eggs, or cheese.
To reduce smells, cover beverages and drink through a straw; choose foods that don’t
need to be cooked; and avoid eating in rooms that are stuffy or too warm.
Strategies to Promote Adequate Nutrition
Freeze fruits like cantaloupe, grapes, oranges, and watermelon, and eat them as
frozen treats.
Blend fresh fruits into shakes, ice cream, or yogurt.
Try flavoring foods with new tastes or spices (onion, garlic, chili powder, basil,
oregano, rosemary, tarragon, BBQ sauce, mustard, ketchup, or mint).
Try marinating meats to make them tender.

Table 6.5 Strategies to address an underlying metallic taste, altered taste, and to promote adequate food intake.
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The Microbiome
The human gut microbiome—the collection of microorganisms residing in the gastrointestinal
tract—is thought to play a role in the etiology of various diseases, including inflammatory bowel
disease1,2,3, type 2 diabetes4,5,6, hypertension7,8,9, and colorectal cancer10,11,12,13. Individual
clinical blood markers, such as those for diabetes14 and cholesterol15, have been found to be
associated with abundances of certain gut bacteria. Lifestyle habits, such as exercise, smoking
and diet can impact the composition of the gut microbial community. For example, diet can
profoundly influence the composition of the microbiome16,17,18. Similarly, physical activity has
been shown to drive shifts in the composition of the gut microbiome in animal models19,20, and
there is preliminary evidence from small-cohort studies that exercise impacts the microbiome in
humans as well21,22,23,24,25. The human gut microbiome is highly individualized, and it
develops across the course of the lifespan. Research demonstrates that birth mode, vaginal
versus cesarean birth, is associated with distinctions in the microbiome at a very young age.
Moving forward from birth, breastfeeding versus bottle feeding practices is also associated with
distinctions in the microbiome composition. Courses of antibiotic use over the lifespan, use of
antibacterial items, living environment, and dietary patterns all affect the human microbiome.
Therefore, a person's microbiome is highly unique, shaped by one's own personal dietary
preferences, genetics, and environmental exposures. This is one of the unique and challenging
aspects of leveraging microbiome science at the population level.
Despite the growth in microbiome research in recent years, large-scale human studies that
integrate gut microbiome profiles with host clinical blood phenotypes, dietary, lifestyle data,
disease diagnoses and medication usage remain scarce. These dense phenotyping studies on
large cohorts are crucial for validating associations established in varying contexts, using sparser
data from smaller cohorts.

3

Inflammatory Bowel Disease (IBD)
Introduction

Inflammatory bowel disease (IBD) is characterized by repetitive episodes of inflammation of the
gastrointestinal tract caused by an abnormal immune response to gut microflora. Inflammatory
bowel disease encompasses two types of idiopathic intestinal disease that are differentiated by
their location and depth of involvement in the bowel wall. Ulcerative colitis (UC) involves diffuse
inflammation of the colonic mucosa. Most often UC affects the rectum (proctitis), but it may
extend into the sigmoid (proctosigmoiditis), beyond the sigmoid (distal ulcerative colitis), or
include the entire colon up to the cecum (pancolitis). Crohn disease (CD) results in transmural
ulceration of any portion of the gastrointestinal tract (GI) most often affecting the terminal ileum
and colon. Both diseases are classified by extent (mild, moderate, or severe) and location. CD
also is classified by phenotype— inflammatory, stricturing, or penetrating. [1][2][3]
Besides the GI tract, both Crohn’s disease and ulcerative colitis have many extraintestinal
manifestations. While in most patients the disorders can be distinguished, in at least 10% of
patients, the features are so similar that it is not possible to initially differentiate between the
two disorders.
Both disorders have a genetic predisposition; neither is curable, and they both carry enormous
morbidity. Finally, both increase the risk of colorectal cancer.

Etiology
Inflammatory bowel disease (IBD) occurs in genetically susceptible individuals after an
inappropriate immune response to the intestinal flora.
To date, the cause of IBD remains a mystery. Many causes have been implicated but none is
universally present in all patients. The one consistent feature of Crohn disease is that it has a
strong link with tobacco. On the other hand, it appears that smoking protects against ulcerative
colitis. The role of diet remains debatable. A few diets have been examined for their efficacy to
control symptoms and/or mitigate inflammation, such as the specific carbohydrate diet (SCD)
and exclusive enteral nutrition (EEN).
The CARD15 gene has been associated with IBD but because of its polymorphic features, it is not
possible to determine which part of the GI tract will be affected. The role of genes in ulcerative
colitis is not as strong as in Crohn disease.
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Epidemiology
The North American incidence of inflammatory bowel disease (IBD) ranges from 2.2 to 19.2 cases
per 100,000 person-years for ulcerative colitis and 3.1 to 20.2 cases per 200,000 person-years for
CD. Prevalence in the United States of adult ulcerative colitis was 238 per 100,000 population
and 201 per 100,000 population from data in a large study based on insurance claims. IBD is much
more prevalent in North America and Europe than in Asia or Africa. Although most IBD occurs in
people age 15 to 30 years, up to 25% of patients will develop IBD by adolescence. There appears
to be a bimodal distribution with a second peak of 10 to 15 percent of cases developing after the
age of 60. Crohn’s disease is slightly more common in females compared to males, but ulcerative
colitis appears to be equally present in both genders. IBD is generally a disorder of developed
countries and colder climates.

Pathophysiology
The intestinal immune system is key to the pathogenesis of inflammatory bowel disease (IBD).
The intestinal epithelium prevents bacteria or antigen entry into the circulation by sealed
intercellular junctions. In IBD, these junctions are defective from either a primary barrier
function failure or because of severe inflammation. Additional protective mechanisms include
mucus production by goblet cells and Paneth cells secretion of a-defensins with intrinsic
antimicrobial activity. Excessive inflammatory reactions lead to continued deterioration of the
epithelium and further exposure to intestinal microbes thereby furthering worsening the
inflammation.
In ulcerative colitis, there is always mucosal inflammation that leads to edema, ulcers, bleeding,
and electrolyte losses. The inflammation in ulcerative colitis usually starts in the rectum and
progresses in an uninterrupted fashion to the proximal colon. In Crohn disease, there are skip
lesions. Skip lesions refers to a phenomenon where physiologically “normal" segments of the
bowel are interrupted by diseased portions. In contrast, in nearly 20% of patients with UC, the
disease remains confined to the rectum. Pancolitis is seen in about 15% of patients. As the
disorder becomes chronic, the colon becomes more rigid and short with a loss of the haustral
markings leading to a “lead-pipe appearance” on a barium enema.
Crohn disease can affect any segment of the GI tract; the disease may induce strictures,
inflammation or lead to the development of fistulas. The key feature of Crohn disease is that it
involves all layers of the bowel (transmural; from lumen to serosa). During the later phase of the
disease, the mucosa will reveal a cobblestone appearance due to the linear ulcers between the
normal mucosa. Crohn disease most generally affects the colon and ileum and only 5% of cases
affect the gastroduodenal segments. Sparing of the rectum is typical of Crohn disease but
anorectal complications like fistulas and abscesses are very common.
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UC predisposes patients to the extraintestinal involvement of the skin, eyes, and bones. Most
commonly these include inflammatory arthropathies and primary sclerosing cholangitis. CD
preferentially attacks the ileum and colon but can involve the esophagus, duodenum, or stomach.
Pediatric-onset cases have greater upper GI tract involvement. As in the case of UC, CD
predisposes patients to extraintestinal manifestations including arthritis, aphthous stomatitis,
uveitis, erythema nodosum, and ankylosing spondyloarthropathy. [5][6]
In Crohn’s disease, the incidence of kidney disease and gallstones is high because of
malabsorption of bile salts and fatty acids. Patients with Crohn disease who undergo resection of
the ileum but have an intact colon are also more likely to develop calcium oxalate renal stones.
Evaluation
Diagnosing inflammatory bowel disease (IBD) requires a combination of clinical findings,
inflammatory laboratory markers, imaging findings, and endoscopic biopsies. Hematologic
findings include microcytic anemia, leukocytosis, and thrombocytosis, inflammatory markers
such as the erythrocyte sedimentation rate (ESR), and high-sensitivity C-reactive protein (hsCRP)
are commonly elevated.[7][8]
In some patients, the diagnosis may require ruling out parasitic diseases like giardia, amebiasis,
strongyloidiasis, and tuberculosis.
A complete blood count will identify anemia, leukocytosis, and albumin levels. Fecal calprotectin
levels can be used as a marker for intestinal inflammation. Levels of perinuclear antineutrophilic
cytoplasmic and anti-saccharomyces cerevisiae antibodies may be elevated in Crohn’s disease.
Finally, stool studies must be done to rule out ova and parasitic organisms.
The abdominal x-ray can assess for the presence of free air, bowel obstruction, or toxic
megacolon. Barium studies are done to characterize the bowel disease; a lead pipe appearance
indicates ulcerative colitis; sparing of the rectum is indicative of Crohn disease and thumb
printing is indicative of mucosal inflammation. Further, the barium studies may reveal skip lesions
and stricture formation in the ileum, which are indicative of Crohn disease.
Ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) have all
been used in the diagnosis of IBD or to assess for complications. US usage in trained individuals
can evaluate the right lower quadrant for ileal disease. MRI can evaluate for rectal fistulas. Most
commonly, CT is employed to evaluate for perforation or bowel obstruction. CT enterography
can be helpful in assessing for strictures or in operative planning.
Endoscopy evaluation with either esophagogastroduodenoscopy, colonoscopy, or both is
essential to obtaining biopsies to confirm a diagnosis of IBD.
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Treatment/Management
The goal of treatment is to induce remission for either UC or CD. Remission is complete absence
of symptoms and underlying inflammation; patients diagnosed with IBD can experience
remission for years to decades. Treatment of IBD is divided into the management of mild,
moderate, and severe disease. Agents formerly reserved for the more severe disease are now
employed sooner. UC treatment depends greatly on the extent of the disease and the presence
of extraintestinal manifestations. For those with mild to moderate disease limited to the rectum,
amino salicylate agents like mesalamine are the mainstays. Mesalamine is administered rectally
but may be combined with oral therapy to induce or maintain remission. For those patients with
the moderate disease who are refractory to mescaline, oral glucocorticoids or
immunomodulators such as TNF-alpha monoclonal antibodies (infliximab) may be an option. Up
to 25% of all UC patients will require total colectomy for the uncontrolled disease.
Proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the procedure of choice for elective
cases.[9][10][11]
Flareups are usually managed with corticosteroid therapy. For those who have more than 1-2
flareups a year, the use of anti-TNF agents or other immunosuppressive is recommended.
CD treatment depends on the portion of the GI tract involved, the degree of fistulizing or
stricturing, and any extraintestinal complications. Treatment of mild ileocecal disease is usually
begun with mesalamine, which can be further augmented with the use of oral budesonide, a
steroid with significant first pass metabolization to limit systemic side effects. For more extensive
disease, systemic steroid therapy with prednisone is necessary. The goal is to wean these steroids
within six weeks. In those patients who cannot wean, an immunomodulating agent like 6mercaptopurine, azathioprine, or low-dose methotrexate is added. In those patients with
moderate to severe disease, anti-tumor necrosis factor (anti-TNF) should be initiated. Before
initiating biologic therapy, patients must complete a purified protein derivative (PPD) test to
assess for latent tuberculosis. Surgical treatment may be necessary for those with severe
fistulizing disease including diverting ostomy.[1][12][13]
It is vital to assess the bone density in patients who are administered steroids; osteoporosis has
significant morbidity in these patients. If steroid use for more than three months is expected,
then calcium supplements and bisphosphonates should be introduced.
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IBD & Microbiome
Adapted from Zhu et al.
Currently, many studies have found that the composition of the gut microbiome in IBD are
significantly altered, which is considered to contribute to this immune disorder (Glassner et al.,
2020). A probable mechanism is that the metabolites of the microbiota regulate metabolic
pathways and inflammatory signal transduction thereby affecting the host immune system. On
the other hand, the gut microbiota may affect the gut immunity through adherent bacteria. Chen
et al. reports that in pediatric IBD, adherent bacteria attached to the terminal ileum were
associated with elevated Th17 cells and SIgA responses (Chen et al.). Previous studies of adherent
bacteria mainly rely on models of immortal cell lines, which cannot reproduce the tissue-like
environment. To address limitations, Mayorgas et al. established a human colonic organoids
model which represents a promising tool to study the cross talk between Adherent-invasive
Escherichia coli and intestinal epithelial cells (Mayorgas et al., 2021).
Studies on the microbial change in pharmaceutical treatment of IBD provide additional evidence
for the microbial contribution in IBD pathogenesis. Dai et al. investigated the pharmaceutical
mechanism of mesalamine in the treatment of UC through 16S sequencing and metabolomics
(Dai et al.). Mesalamine is a radical scavenger and antioxidant, often used to treat UC. The
authors observed that the abundance of some bacteria and metabolites were reversed toward
the healthy status after mesalamine treatment. Similarly, as summarized in this issue by Li et al.,
many natural products may exert their therapeutic effects on the gut microbiota in the treatment
of IBD (Li et al.). These studies reveal possible molecular mechanisms of naturally derived
polysaccharides from plants, seaweeds, and mushrooms in the treatment of IBD, and identified
many potential clinical therapeutic targets. In the same direction, Guo et al. reports that ginger
can significantly increase the diversity of intestinal microbiome and alleviate the severity of UC
(Guo et al.). This study suggests that the abnormality of the microbiome is closely related to
amino acid metabolism, oxidative phosphorylation, protein translation, and ribosome biogenesis.
The study of Zhao et al. is unique in utilizing a nano-targeted drug delivery system to achieve a
highly efficient delivery of berberine (Zhao et al.), which effectively regulated inflammation and
reconstructed the intestinal microbial community.
Collectively, studies have demonstrated that the microbiome is a key lever in the diagnosis and
progression of IBD. Further, microbiome science has expanded to identify key dietary patterns
and even foods that have beneficial versus deleterious effects on the diversity and functional
capacity of the gut microbiome (Figure 7.1). Beneficial nutrients and foods increase alphadiversity and beneficial bacteria populations while decreasing pathobionts. They also increase
protective mucus secretions, improve tight junctions and the production of antimicrobial
molecules. The effects on immune cells are also illustrated in Figure 7.1, with increasing Treg cell
numbers and production of anti-inflammatory cytokines. In contrast, harmful nutrients/ foods
decrease alpha-diversity, beneficial bacterial levels and increase pathobionts, thereby decreasing
mucus secretions and reducing the strength of tight junctions. Concurrent changes in immune
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cells include increasing Th1/Th2, Th17 as well as pro-inflammatory cytokines that go on to further
exacerbate damage to mucosal immunity, creating a vicious cycle of dysbiosis, inflammation, and
epithelial damage.

Figure 7.1 Nutrients and foods in the pathogenesis of inflammatory bowel disease. Epidemiological,
clinical, and animal studies have demonstrated that certain components of diet are associated with IBD.
Diet plays a critical role in intestinal homeostasis, including the gut microbiota, intestinal mucosal barrier,
and mucosal immune system. Dietary patterns directly modulate the mucosal barrier and immunity,
whereas diet-microbiota interaction also regulates the intestinal homeostasis.
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Precision Nutrition in IBD – an Opportunity for new Research
Adapted from Hurtado-Lorenzo et al.

The Crohn’s & Colitis Foundation has established a Precision Nutrition (PN) initiative to further
understand how diet affects IBD, particularly at the individual patient level. This is a critical gap
in the understanding and management of IBD, and an area of opportunity to make a significant
impact on the quality of life of patients. The long-term goal of the PN initiative is to be able to
answer the IBD patient’s key question, “what should I eat,” based on the patient’s personal
response to different foods, so that diets can be tailored to the individual clinical, biological, and
lifestyle characteristics of the patient.
Driven by a multi-institutional approach, this initiative integrates several key elements needed to
assemble the “IBD precision nutrition puzzle,” with the overarching goal of providing unified
scientific evidence to support the implementation of personalized diet recommendations for the
management of IBD. Key elements are: (1) evaluation of rationally designed anti-inflammatory
diets to improve disease outcomes in randomized clinical trials (orange in Figure 7.2), (2)
identification of biomarkers to predict subgroups of IBD patients who are responders and
nonresponders to these anti-inflammatory diets (blue in Fig. 7.2), (3) identification of
proinflammatory “trigger foods” that can exacerbate symptoms or induce disease relapse (green
in Fig. 7.2), and (4) development of in silico predictive tools required to design evidence-based
therapeutic diets, whose efficacy can be evaluated in trials (pink in Fig 7.2). A critical unifying
element at the core of this initiative is the use of artificial intelligence (AI)-based analysis of
multiomics data for the identification of the biomarkers required to make predictions of patients’
response to food, in order to enable precise and effective therapeutic diet recommendations.

Figure 7.2 Key components of the Crohn’s & Colitis Foundation’s precision nutrition initiative for IBD.
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Celiac Disease
Adapted from Valitutti et al.

The recognition of the causal link between gluten and celiac disease (CD) was unveiled in the
1950s [1], but the factor (or factors) that trigger the loss of immune tolerance to gluten in
genetically predisposed subjects remains unknown. Since its original description, CD has most
often been perceived as a pediatric condition with a peak incidence in children younger than two
years of age, with more recent data suggesting that most of the cases would manifest by five
years of age [2].
The worldwide prevalence of CD ranges between 1% and 2% in the general population [3,4], with
most patients remaining undiagnosed due to the subtle or multiform clinical manifestations of
the disease [5]. Based on more recent data, it is now appreciated that CD can present at any age
with a broad range of intestinal and extra-intestinal symptoms [6,7]. Its prevalence, as in many
other autoimmune diseases often found in comorbidity with CD [8], has increased over time in
geographical regions characterized by a Western lifestyle [9]. This phenomenon was initially
hypothesized to be secondary to the timing of gluten introduction at weaning [10], although two
large, randomized, and prospective high-risk, birth cohort-controlled trials have disputed this
premise by demonstrating that neither delayed nor early gluten introduction modified the risk of
CD [2,11].
These findings raised doubts about another CD paradigm that suggested that genetic background
and dietary gluten intake were necessary and sufficient to develop the disease. Besides the
evidence that CD onset can occur years after gluten introduction into the diet [6], other evidence
at odds with the old paradigm is the lack of 100% CD concordance among monozygotic twins
[12]. Therefore, while genetic predisposition (including the required presence of HLA DQ2 and/or
DQ8 haplotypes) and gluten exposure are necessary, they seem to be insufficient for the
development of CD autoimmunity. Intestinal permeability is an additional element involved in
CD pathogenesis, as a “leaky gut” might initiate the early phases of innate immune activation
following the exaggerated trafficking of undigested gluten fragments from the intestinal lumen
to the lamina propria
[13].
Important to note, CD
itself is an
autoimmune
condition that is
distinct from gluten
allergy or gluten
sensitivity (Figure
7.3).
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Figure 7.3. Pathogenesis of wheat-related disorders: auto-immune, allergy and innate immunity.

Celiac Disease and Microbiome
Growing evidence supports the hypothesis that changes in gut microbiome composition and
function are associated with several chronic inflammatory diseases, including obesity [14],
diabetes [15], inflammatory bowel disease [16] and cancer [17]. This might also be the case for
CD.
In the last decades, one of the major advances in the field of microbiome studies has been the
ability to apply culture-independent approaches to determine the microbiome’s composition
[18]. These technologies allow for the identification and quantification of components of the
human microbiota by studying nucleic acids (DNA and RNA) from fecal samples or other biological
samples [19], which eliminates the need for tissue cultures and allows the characterization of
non-cultivable microbes.
Gut bacteria facilitate the digestion of insoluble fiber, produce vitamins such as vitamin K, and
elaborate trophic and immunomodulating compounds such as short-chain fatty acids (SCFA) [24].
Moreover, they also display key immune-modulating functions within the gut. By competing for
nutritional sources and producing anti-microbial molecules, beneficial gut bacteria
counterbalance the growth of pathogenic bacteria and favor epithelial integrity [25,26].
Microbiome-derived SCFA can also modulate host histone deacetylase, therefore epigenetically
influencing the function of innate and adaptive immune cells [27]. The impact of the gut
microbiome on mucosal immunity is further demonstrated by the evidence of defects in
lymphoid tissues (fewer mucosal Peyer’s patches and smaller mesenteric lymph nodes) and
compromised antibody production in germ-free animals [28].
Bifidobacterium and Lactobacilli Strains are players in Pathogenetic Interactions
In the pursuit of the best microbial candidate for disease immunomodulation, a few
Bifidobacteria strains have been studied with considerable results. For example, in an in vitro
model using peripheral blood mononuclear cell (PBMCs), both Bifidobacterium longum ES1 and
Bifidobacterium bifidum ES2 have been shown to downregulate the Th1 pathway typical of CD
[81].
In addition, Lindfors et al. assessed whether Bifidobacterium lactis can neutralize the toxicity of
gliadin. In Caco-2 cells, they found that this strain was at least able to reduce the epithelial
permeability triggered by gluten [82]. Laparra et al. evaluated Bifidobacterium longum CECT
7347 in a murine model of CD, and they found that this specific strain not only diminishes proinflammatory cytokine synthesis, such as tumor necrosis factor-alfa (TNF-alfa), but it also reduces
jejunal architecture damage [83]. Another group has demonstrated that Bifidobacterium longum
strain NCC2705 produces a serine protease inhibitor with immune-modulating features, i.e.,
attenuating gliadin-induced histological damage in NOD/DQ8 mice [84].
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An alternative Bifidobacterium, B. infantis, seems to decrease Paneth cells and expression of alfadefensin-5 on electronic microscopy of duodenal biopsy when administered in active CD [85].
Paneth cells are key masters of gut homeostasis in innate immunity against noxious pathogens
through the release of defensins, lysozyme and phospholipase [86]. Furthermore, some evidence
concerning the protective effect of Lactobacillus casei DN-114001 and E. Coli strain Nissen 1917
on gut barrier function has been reported [87].
D’Arienzo et al. analyzed the effect of Lactobacillus casei, Lactobacillus paracasei, and
Lactobacillus fermentum in a transgenic mouse model expressing human DQ8. They found that
L casei reduces TNF-alfa secretion and related villous blunting, while both L paracasei and L
fermentum determine increased antigen-specific TNF-alfa. This suggests that, depending on the
strain and on the experimental model, probiotics may have either proinflammatory or
immunomodulatory properties [88,89].
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Irritable Bowel Syndrome (IBS)
Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders
encountered in clinical practice. It is a heterogeneous disorder with a multifactorial pathogenesis.
Recent studies have demonstrated that an imbalance in gut bacterial communities, or
“dysbiosis,” may be a contributor to the pathophysiology of IBS. There is evidence to suggest that
gut dysbiosis may lead to activation of the gut immune system with downstream effects on a
variety of other factors of potential relevance to the pathophysiology of IBS.
Dietary factors are central for patients with IBS, and most patients report worsening of symptoms
after intake of certain trigger food items, particularly foods containing refined carbohydrates or
fat. This may be due to diet–microbiota interactions since gut microbes have an important role
in the digestion of dietary components and fermentation of indigestible fibers that may directly
or indirectly contribute to IBS symptoms. Food items rich in indigestible carbohydrates (i.e.,
fermentable oligosaccharides, disaccharides, monosaccharides, and polyols [FODMAPs]) seem to
be particularly relevant, because they can provoke IBS symptoms in susceptible individuals
through osmosis and fermentation. Several studies have demonstrated the clinical efficacy of a
low FODMAP diet in IBS, an effect that goes beyond the placebo response frequently reported in
patients with IBS, but not clearly superior to traditional IBS dietary advice.
The clinical effect of a low FODMAP diet is partly mediated through diet–microbiota interactions;
a reduction of carbohydrates, that is, the substrate for bacterial fermentation in the colon, leads
to lowered gas production and thereby reduced intestinal distension. However, the physiologic
responses to FODMAP intake, that is, the effect on luminal water content, gas production, and
degree of luminal distension, do not seem to differ between patients with IBS and healthy
controls, but colonic hypersensitivity to distension, rather than excessive gas production, seems
to be the main cause of carbohydrate-related symptoms in patients with IBS. Regarding gut
microbiota, a low FODMAP diet leads to substantial changes in gut microbiota composition with
a decrease in gut microbes putatively associated with health, such as bifidobacteria, which may
seem counterintuitive. However, the relevance of changes in the gut luminal microenvironment
and changes in symptoms remain unclear. Furthermore, gut microbiota composition before
starting a low FODMAP diet seems to be a predictor for the symptom response, highlighting the
relevance of diet–microbiota interactions for efficacy.
Bellini et al. advocate for future uses and utility of the low FODMAP diet for patients diagnosed
with IBS, proposing a dietary management flowchart that emphasizes personal optimization by
way of initial clinical and dietary assessments (Figure 7.4).
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Figure 7.4 Dietary management flowchart for patients diagnosed with irritable bowel syndrome (IBS); focused on low-FODMAP approach.
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Chronic Kidney Disease
Adapted from NIDDK Website
Chronic kidney disease (CKD) means a patient’s kidneys are damaged and can’t filter blood the way they
should. The disease is called “chronic” because the damage to one’s kidneys happens slowly over a long
period of time. This damage can cause wastes to build up in the body. CKD can also cause other health
problems. The kidneys’ main job is to filter extra water and wastes out of blood to make urine. To keep a
body working properly, the kidneys balance the salts and minerals—such as calcium, phosphorus, sodium,
and potassium—that circulate in the blood. The kidneys also make hormones that help control blood
pressure, make red blood cells, and keep bones strong.
Kidney disease often can get worse over time and may lead to kidney failure. If kidneys fail, patients will
need dialysis or a kidney transplant to maintain their health.
People are at risk for kidney disease if they have:
•

•

•

•

Diabetes. Diabetes is the leading cause of CKD. High blood glucose, also called blood sugar, from
diabetes can damage the blood vessels in the kidneys. Almost 1 in 3 people with diabetes has
CKD. Type 2 diabetes is the number one cause of kidney failure. This statistic underscores the
importance of managing diabetes and keeping blood sugar under control. Tight control has
immense benefits by reducing the risk for kidney disease.
High blood pressure. High blood pressure is the second leading cause of CKD. Like high blood
glucose, high blood pressure also can damage the blood vessels in your kidneys. Almost 1 in 5
adults with high blood pressure has CKD.
Heart disease. Research shows a link between kidney disease and heart disease. People with heart
disease are at higher risk for kidney disease, and people with kidney disease are at higher risk for
heart disease. Researchers are working to better understand the relationship between kidney
disease and heart disease.
Family history of kidney failure. If one’s mother, father, sister, or brother has kidney failure, there
is a risk for CKD. Kidney disease tends to run in families. People who have kidney disease should
encourage family members to get tested. People with CDK can use tips from the family health
reunion guide and speak with their family during special gatherings.

Other health problems that can cause CKD include glomerular diseases that attack blood vessels in the
nephrons (the functional unit of the kidney); focal segmental glomerulosclerosis (FSGS) is such an
example. Polycystic or other cyst diseases can cause fluid filled bubbles to replace normal kidney tissue.
Tumors or cancer in the kidneys, as well as lupus (an auto-immune condition that may attack the skin,
joints, kidneys, and brain). The chances of having kidney disease increase with age. The longer a person
has had diabetes, high blood pressure, or heart disease, the more likely that they will have kidney disease.
African Americans, Hispanics, and American Indians tend to have a greater risk for CKD. The greater risk
is due mostly to higher rates of diabetes and high blood pressure among these groups. Scientists are
studying other possible reasons for this increased risk.
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There are five stages of CKD; the criteria for determining which stage a patient falls in is decided by two
GFR test at least 90 days apart. Stages 1 and 2 occur only in people whose kidneys are abnormal. For
example, they may have been born with one kidney, born with kidney cysts, or have urine that backs up
into the kidneys. Most people find out they have CKD at stages 3, 4, or 5. In the early stages, the risk of
heart disease is higher than later stages, so efforts should be made to protect both the kidneys and the
heart.

Figure 8.1 The 5 stages of CKD, based on two GFR tests separated by at least 90 days.
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Nutritional Considerations
Adapted from Molina et al.
A caloric intake of 25–35 kcal/kg/day is recommended to counteract the excess resting energy
expenditure secondary to inflammation and comorbidities, as well as for preserving a neutral or positive
nitrogen balance. However, this recommendation should be individualized according to the patient's
profile, including age, lean body mass (which is the primary determinant of energy expenditure), physical
activity, and the underlying etiology of kidney disease (20, 21). According to the 2020 Kidney Disease
Outcomes Quality Initiative (KDOQI) guidelines, the recommended protein intake for stable patients with
ND-CKD 3–5 dialysis is 0.55–0.60 g/kg/day, which can be reduced to 0.28–0.43 g/kg/day if it is
supplemented with 7–15 g/day of KAs (keto analogs) and essential AAs (amino acids). In the case of
diabetic patients, guidelines suggest a higher protein intake up to 0.6–0.8 g/kg/day to glycemic control.
Any intercurrent catabolic episode may require increasing energy and protein intake independently of
CKD stage (22).
A modest sodium restriction (<2.3 g/day) is recommended for the management of CKD patients to achieve
better volume control, reducing blood pressure (BP), and proteinuria synergistically with available
pharmacologic interventions (18). A daily fiber intake of 25–30 g/day or more for CKD patients may be
suggested, with this amount like recommendations for the general population (7). Potassium restriction
in CKD may prevent from complying with this recommendation but in general terms CKD patients do not
require aggressive dietary potassium restriction until advanced stages or if hyperkalemia risk is judged
high (24–26). Recently, it has been suggested to avoid high potassium foods with poor nutritional value
(i.e., bran products, or salt substitutes) and correct other causes of hyperkalemia, such as metabolic
acidosis or use of renin-angiotensin-aldosterone system (RAAS) inhibitors, before restricting healthy foods
(27). Given the role of calcium balance and the serum phosphate in the development of cardiovascular
calcifications, several experts recommend limiting total dietary calcium intake to 800–1,000 mg/day or
less (including dietary calcium, calcium supplementation, and calcium-based phosphate binders) in adults
with CKD 3–4 not taking active vitamin D analogs. Although phosphate intake to 800–1,000 mg/day (800–
1,300 in KTR) was recommended previously (29, 30), new guidelines suggest adjusting dietary phosphorus
intake to maintain serum phosphate levels in the normal range (18). Limiting processed foods with
phosphorous-based additives and encouraging home-cooked meals from fresh ingredients (preferably
plant-based foods) should be the first-line interventions for phosphorus restriction (31). As in the general
population, vitamin D intake for CKD patients is recommended at 600–800 IU/day, but the optimal vitamin
D levels in serum remain controversial (31, 32).
Low Protein Diet (LPD)
The benefits of LPDs include slowing the progression of CKD and reducing uremic symptoms and
metabolic disorders (20, 21, 48, 49). Nearly 20 randomized controlled trials (RCTs) have assessed the
effects of protein restriction on several renal outcomes, including CKD progression, proteinuria,
phosphate levels, acidemia, and BP, which have been summarized in several meta-analyses and two
Cochrane reviews (8–11, 15, 16, 50–56). Overall, the balance of evidence suggests a benefit of dietary
protein restriction. The 2020 KDOQI guidelines recommend, in non-diabetic adults with CKD 3–5 who are
metabolically stable, protein restriction for reducing the risk of progression to end-stage renal disease
(ESRD) and death and improve quality of life. In adults with CKD 3–5 and who have diabetes, the guidelines
suggest a higher protein intake up to 0.8–0.9 g/kg/day (18). For the study of the effect of LPD on survival,
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they identified five RCTs. Three studies clearly indicated a beneficial effect of moderate restriction in
dietary protein in the development of end stage renal disease (ESRD)/renal death (57–60), whereas two
studies did not (61, 62). The results of the secondary analysis on the number of ESRD/renal death events
combined from the three positive studies indicated a beneficial effect of protein restriction (OR 0.621;
95% CI: 0.391–0.985).
For the effect of LPD on quality of life, they identified a single RCT that demonstrated how the group with
protein restriction presented significantly higher scores for general health and state physical compared to
the control group (62). For the study of the effect of VLPD (very low protein diet) supplemented with AAEs
and KAs, they reviewed a total of 13 RCTs and one non-RCT (63–76). The pooled analysis indicated a
probable overall benefit of VLCD+KAs supplementation for the development of ESRD/renal death in
patients with CKD stages 3–5 (RR 0.65; 95% CI: 0.49–0.85). After the 2020 K-DOQI guidelines, a new
systematic review and meta-analysis explored the effectiveness and safety of VLCD supplemented with
KAs compared to LPD or a normal protein diet in patients with CKD (15). Seventeen RCTs with a total of
1,459 patients were included. KAs-supplemented VLCD significantly conserved GFR and reduced
proteinuria, phosphorus, and parathyroid hormone levels, systolic and diastolic BP, as well as serum
cholesterol. Additionally, the analysis by subgroups showed how the VLPD supplemented with KAs was
superior to the LPD with KA in the rate of decrease in GFR.
Animal vs. Plant-based Protein
Several observational studies have suggested that plant proteins may have more reno-protective effects
than animal proteins. A diet rich in protein from plant sources may slow the progression of CKD (88–92),
decrease proteinuria (93, 94), lower the level of uremic toxins (94–99), phosphorus intake, and the
endogenous production of acid (89, 90, 100, 101). Moreover, such a diet could potentially improve survival
(102). However, the confounding factors inherent in a diet rich in plant-based protein (i.e., higher intakes
of vitamins and antioxidants) make it difficult to draw definite conclusions (103, 104).
Dietary Salt
Dietary sodium intake is a modifiable factor that can impact on the risk of CKD progression as well as
on cardiovascular disease in CKD patients. Previous reports have demonstrated the effect of sodium
intake on fluid overload and hypertension, both predictors of kidney progression and cardiovascular
remodeling (105–109). In addition, high sodium intake might have direct toxic effects on blood vessels
(109, 110). High salt intake is also a well-established risk factor for hypertension in KTR and can result in
decreased graft survival (2, 111).
Conversely, salt restriction RCTs demonstrate a reduction in BP and proteinuria, with potential benefits
on CKD progression and survival (5). A Cochrane review summarized the effects of salt restriction in CKD
(8). Unfortunately, these studies did not show collectively a beneficial effect of a lower sodium intake on
mortality, cardiovascular events, or CKD progression, probably due to their short follow-up and the limited
sample size. It is interesting to highlight a significant decrease in proteinuria associated to a low salt diet,
that was observed in all the RCTs that reported this outcome (112–115). The 2020 KDOQI guidelines
recommend in adults with CKD 3–5, CKD 5D, or post-transplantation, a limitation in the sodium intake to
<2.3 g/d (<100 mmol/d) to achieve a BP reduction, an improvement in volume control and a decrease in
proteinuria levels (18). Nevertheless, the lack of long-term RCTs assessing the effectiveness and safety of
dietary salt restriction on CKD progression and survival prevents any firm conclusions.
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Reduced Phosphorus
Phosphate-specific diet therapy provided by a dietitian may reduce phosphate levels in CKD, although
overall certainty of evidence is low (116). However, association between hyperphosphatemia and adverse
cardiovascular outcomes and CKD progression is robust in this population (117–124), also in KTR (125–
127). Altogether, it seems reasonable to recommend adjusting dietary phosphorus intake to maintain
serum phosphate levels in the normal range (18, 105).
Dietary Patterns & CKD Progression
Historically, research recommendations and guidelines have focused primarily on modifying the single
intake of micro or macronutrients (57). However, changes to eating habits remain minor, over time, for
everyone, so that the overall dietary pattern may be more decisive for patients than an excess or
deficiency in one specific nutrient (103). Adherence to healthy diet patterns as the Mediterranean and
the DASH (The Dietary Approach to Stop Hypertension) diets has been linked to less rapid kidney function
decline and favorable effects on cardiovascular morbidity and mortality in ND-CKD patients, including
kidney transplant recipients (KTR) (140, 141). Plant-based diets could also mitigate metabolic acidosis in
patients with CKD and potentially slow the progression of kidney disease, but evidence is limited (104).
Conversely, a Western diet (rich in saturated fat, red and processed meat, and sweets) has been
associated with an increased
risk of CKD progression and
albuminuria
(142).
The
evidence is not conclusive as
not all studies associate
healthy dietary patterns and
risk of ESRD (143). Collectively,
there is a possibility that
healthy dietary patterns may
prevent the development of
ESRD (5, 81, 146). Figure 8.2 is
a schematic representation of
reno-protective mechanisms
related to protein and diet
prescription, as well as
synergy with pharmacologic
approaches that target the
renin-angiotensin
system
(RAS).
Figure 8.2 The effects of
different nutritional
interventions to slow
progression of CKD.
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